Poster-Presenters - CBD S&T Conference

December 2-5, 2024 |
Fort Lauderdale, Florida

December 2-5, 2024 | Fort Lauderdale, Florida

December 2-5, 2024 | Fort Lauderdale, Florida

Poster Presentations

Poster Presenters Listing & Layout

The poster presentation list is sorted by poster session day (Wednesday or Thursday) then poster number. Please use the search function to locate presenter name, title, session, or poster presentation day. For additional sorting options click column headers.

View Poster Session Floorplans

Wednesday

poster map

Thursday

poster map

Click to view poster map

Click to view poster map

Poster Presentation Day	Poster Number	Poster Presenter	PA Organization	Submission ID	Topic	Submission Title	Room	View Abstract
W	1	Stephen Hummel	U.S. Army / Boston College	106	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	digitalSELEX: An in silico Oligonucleotide Design Platform for Biosensors and Therapeutics	Exhibit Hall D	View Abstract
Th	2	Kamil Musilek	University of Hradec Kralove	123	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	AI can be used for identification of modified oxime nucleophiles with enhanced cholinesterase reactivation	Exhibit Hall D	View Abstract
W	3	Harshini Mukundan	Los Alamos National Laboratory	146	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Intelligent Immunity – Modeling Innate Immune Responses for Agnostic Diagnostics, Therapeutics and Prediction of Disease Severity	Exhibit Hall D	View Abstract
Th	4	Mark Weston	Netrias, LLC	227	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	AI Assisted Multi-Omics Data Harmonization and Integration	Exhibit Hall D	View Abstract
W	5	Allison Melka	Excet support to US Army DEVCOM Chemical Biological Center	235	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Proteomic, metabolomic, and lipidomic analyses of lung tissue exposed to mustard gas	Exhibit Hall D	View Abstract
W	6	Francine Katz	The City College of New York	287	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Regulation of actin depolymerization resulting from exposure to choking agent	Exhibit Hall D	View Abstract
W	7	Francine Katz	The City College of New York	292	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Effectors that Reduce Aging of Organophosphate Adducts of Acetylcholinesterase	Exhibit Hall D	View Abstract
Th	8	Bowen Jing	MIT	323	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Torsional Diffusion for Molecular Conformer Generation	Exhibit Hall D	View Abstract
W	9	Sayak Mukherjee	Battelle	344	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Deep learning QSAR modeling for fraction unbound in human plasma	Exhibit Hall D	View Abstract
Th	10	Ping Gong	US Army Engineer Research and Development Center	434	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Development of a novel acetylcholine sequestration-based countermeasure for nerve agent poisoning	Exhibit Hall D	View Abstract
W	11	Miranda Paley	DHS Science & Technology	474	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Assessing Computational Toxicology for Applications in Homeland Defense	Exhibit Hall D	View Abstract
Th	12	Karissa Sanbonmatsu	Los Alamos National Laboratory	528	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Using machine learning to establish a baseline for detection of epigenetic infection signatures	Exhibit Hall D	View Abstract
W	13	Vivian Lin	PNNL	543	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Discovery of non-canonical protein targets of chemicals of concern using activity-based protein profiling (ABPP)	Exhibit Hall D	View Abstract
Th	14	Brian Bennion	LLNL	573	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	A Community Effort to Catalog the Reactivation of Acetylcholineesterase by Small Molecules	Exhibit Hall D	View Abstract
W	15	Fangqiang Zhu	Lawrence Livermore National Laboratory	583	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Large-scale application of free energy perturbation calculations for antibody design	Exhibit Hall D	View Abstract
Th	16	C. Linn Cadieux	USAMRICD	597	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Improved Nerve Agent Treatment System Early Development Pipeline (INATS EDP): Utilizing in silico, in vitro, ex vivo, and in vivo assays in human-relevant systems to evaluate proposed reactivator drug candidates as organophosphorus nerve agent countermeasures	Exhibit Hall D	View Abstract
W	17	Cynthia Van Acker	Oak Ridge Institute of Science and Education Program; United States Army Medical Research Institute of Chemical Defense	598	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Developing an Assay to Further Elucidate the Interactions of Chemical Warfare Agents and Reactivators with Acetylcholinesterase	Exhibit Hall D	View Abstract
Th	18	Benjamin Wadsworth	Oak Ridge Institute for Science and Education; United States Army Medical Research Institute of Chemical Defense	600	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Exploring the utility of a human-relevant mouse model for detecting and quantifying medical countermeasures in the brain.	Exhibit Hall D	View Abstract
W	19	Nathan Tatum	ARA	617	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Physiology-based modeling to explore repeat dosing of nasal naloxone after opioid overdoses	Exhibit Hall D	View Abstract
Th	20	Nicholas Paparoidamis	US Army Medical Research Institute of Chemical Defense	667	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Development of a Structure-Activity Relationship for Analogs of a Non-Oxime Reactivator for Nerve Agent-Inhibited Acetylcholinesterase	Exhibit Hall D	Abstract unavailable.
W	21	Thomas Lane	Collaborations Pharmaceuticals, Inc	674	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Machine Learning Models For Predicting Human Liver Microsomal Metabolism of Organophosphate Pesticides	Exhibit Hall D	View Abstract
Th	22	David Crary	Applied Research Associates, Inc	714	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Towards a Toxicokinetic Model of Nerve Agent Injuries in Humans	Exhibit Hall D	View Abstract
W	23	Matthew Coleman	Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, CA, USA	730	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Demonstrating biological protection using nanoparticle technologies to improve neutrapharmecueticals bioavailability for CBRN:	Exhibit Hall D	View Abstract
Th	24	Ramesh Jha	Los Alamos National Laboratory	737	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	High throughput test tools for expedited and ML-assisted enzyme design	Exhibit Hall D	View Abstract
W	25	Celisha Oscar	SPA	753	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	The Use Of O-alkylation To Enhance Structural Stability and Biological Activity of Rotigotine	Exhibit Hall D	View Abstract
Th	26	Sofiya Micheva-Viteva	Los Alamos National Laboratory	91	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Human NMJ-based Microphysiological System for Discovery and Evaluation of Medical Countermeasures against Chemical Threats	Exhibit Hall D	View Abstract
W	27	Anders Wallqvist	US Army	93	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	Machine learning and AI applications for assessing chemicals and drugs	Exhibit Hall D	View Abstract
W	28	Anders Wallqvist	US Army	94	AI/ML and Virtual Human Platforms for Threat Agent Hazard Assessment and Medical Countermeasure Discovery and Drug Development	ToxProfiler: Toxicity-target profiler based on chemical similarity	Exhibit Hall D	View Abstract
Th	30	Steve Hadeed	DTRA Reachback	198	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Notional Spread of Cholera in Haiti Following a Natural Disaster	Exhibit Hall D	View Abstract
W	31	Elizabeth Dhummakupt	US Army DEVCOM Chemical Biological Center	218	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Metabolic and proteomic profiling of organophosphorus chemical warfare agent exposure on human liver-on-a-chip	Exhibit Hall D	Abstract unavailable.
Th	32	Thomas Ingersoll	U.S. Army DEVCOM Chemical Biological Center	329	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Estimators for disease dynamics with imperfect surveillance	Exhibit Hall D	View Abstract
W	33	Camilo Valdes	Lawrence Livermore National Laboratory	436	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Learning Microbial Representations with Hilbert Curve Visualizations	Exhibit Hall D	View Abstract
Th	36	Sarah Schmitt	ARA	655	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Modeling Warfighter Performance Degradation Following Chemical/Biological (CB) Exposures: Improving Model Outputs to Better Estimate Mission Readiness and Force Lethality	Exhibit Hall D	View Abstract
W	37	Jonathan Pinney	Gryphon Scientific LLC	659	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Towards Risk Assessment: A Quantitative Analysis of Global Biological Research	Exhibit Hall D	View Abstract
Th	38	Paul Fenimore	Los Alamos National Laboratory	666	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Fast, efficient prediction of epidemic dynamics with variable size data input and good output fidelity	Exhibit Hall D	View Abstract
W	39	Jennifer Corbin	Gryphon Scientific	693	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Development of a Data-Driven Tool to Assess Epidemiological Model Prediction Accuracy	Exhibit Hall D	View Abstract
Th	40	Mario Citra	SRC, Inc.	702	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	Leveraging Regulatory Models and Data for CB Operational Hazard Prediction	Exhibit Hall D	View Abstract
Th	41	Jason Rodriguez	Applied Research Associates, Inc	713	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	A Novel Framework for Modeling Person-to-Person Transmission of Respiratory Diseases	Exhibit Hall D	View Abstract
Th	42	Jason Rodriguez	Applied Research Associates, Inc	728	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	FXCODA: A Human Health Effects Module for DTRA Platforms	Exhibit Hall D	View Abstract
W	43	Ece Bulut	Cornell University	742	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	FInd CoV Control decision support tool forecasts the effects of COVID-19 on human health and productivity in the food industry sector	Exhibit Hall D	View Abstract
Th	44	Jeffrey Price	Vala Sciences, Inc.	749	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	AI-Enabled in vitro Cardiotoxicity Assay of hiPSC-Cardiomyocytes, 2nd Iteration Goal: Increase Human Response Predictivity from 90% to 95%	Exhibit Hall D	View Abstract
W	45	Riccardo D'Elia	Defence Science and Technology Laboratory	153	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Non Ionic Surfactant Vesicles as drug delivery and targeting systems for antimicrobials	Exhibit Hall D	View Abstract
W	47	Lauren Panny	Biomedical and Veterinary Science, Virginia Polytechnic Institute, Christiansburg, VA	189	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Inhibition of protein disulfide isomerases as a broad-spectrum anti-viral target	Exhibit Hall D	View Abstract
Th	48	Thomas Laws	DSTL	196	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Towards Immunotherapy against alphaviral encephalitis	Exhibit Hall D	View Abstract
W	49	Paul Stewart	Tranexamic Technologies	291	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Repurposing tranexamic acid as a broad spectrum antiviral nasal spray against respiratory viruses	Exhibit Hall D	View Abstract
Th	50	Mahgol Behnia	Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA	294	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Inactivation of Venezuelan equine encephalitis virus genome using two methods	Exhibit Hall D	View Abstract
W	51	Nileena Velappan	Los Alamos National Laboratory	311	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Developing Affinity Reagents for Novel Diagnostic Assays	Exhibit Hall D	View Abstract
Th	52	Stephanie Monticelli	USAMRIID	322	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	EVALUATION OF PROTECTIVE ANTIBODIES FROM HUMAN SURVIVORS OF CRIMEAN-CONGO HEMORRHAGIC FEVER	Exhibit Hall D	View Abstract
W	53	Se Hun Gu	Agency for Defense Development	327	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Small interfering RNA inhibit the severe acute respiratory syndrome coronavirus 2 infection	Exhibit Hall D	View Abstract
Th	54	James Mullin	Lankenau Institute for Medical Research	339	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	The Centrality of Epithelial and Endothelial Barrier Leak in Pathogen-Based Disease: Leak Reduction by Elevated Levels of Tissue-Specific Micronutrients as a Prophylactic and Therapeutic Countermeasure	Exhibit Hall D	View Abstract
W	55	Rachel Ireland	Defence Science and Technology Laboratory	340	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Approaches to develop icDNA clones of encephalitic alphaviruses to characterize viral disease and evaluate broad-spectrum therapeutics	Exhibit Hall D	View Abstract
W	56	Aarthi Narayanan	George Mason University	352	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Inhibitors of the ubiquitin-proteasome pathway as broad-spectrum countermeasures against acutely infectious viruses	Exhibit Hall D	View Abstract
W	57	Aarthi Narayanan	George Mason University	363	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Brilacidin as a novel broad-spectrum antiviral countermeasure against acutely infectious viruses	Exhibit Hall D	View Abstract
Th	58	Simon Galer	MedinCell	370	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	MedinCell®: Developing Long-Acting Injectables of Small Molecule Drugs to Biologics, Targeting Systemic or Local Delivery, Aiming to Provide Optimal Sustained Drug Exposure from a Single Injection.	Exhibit Hall D	View Abstract
W	59	Marwah Karim	Stanford University	390	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	A novel class of small molecule inhibitors of PIKfyve potently suppresses encephalitic alphavirus infections	Exhibit Hall D	View Abstract
Th	60	Sarah Sandholtz	Lawrence Livermore National Laboratory	394	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	A computational pipeline to identify broad-spectrum drug targets and interacting chemotypes in viral pathogens	Exhibit Hall D	View Abstract
W	61	Dina Weilhammer	Lawrence Livermore National Lab	400	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Building a molecular atlas of blood brain barrier disruption by Venezuelan equine encephalitis virus	Exhibit Hall D	View Abstract
Th	62	Deepika Awasthi	Lawrence Berkeley National Lab	413	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Engineered probiotics- a platform for discovery and evaluation of oral therapeutics	Exhibit Hall D	View Abstract
W	63	Andrew Herbert	USAMRIID	437	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Developing human monoclonal antibody-based therapies for hemorrhagic fever viruses	Exhibit Hall D	View Abstract
Th	64	Na Young Kim	R&D Center, ABION INC., Seoul 08394, Republic of Korea	450	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Developing of siRNA therapeutic platform for immediate respond against emerging viral pathogens	Exhibit Hall D	View Abstract
W	65	Hong Seok Choi	Research Center, Abion Inc., 08394 Seoul, Republic of Korea	453	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Development of ABN101, Interferon-beta mutein, as a broad-spectrum antiviral drug	Exhibit Hall D	View Abstract
Th	66	Mohamad Ammar Ayass	Ayass Bioscience LLC	481	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	A Safe and effective neutralizing DNA aptamer therapy for combating SARS-CoV-2	Exhibit Hall D	View Abstract
Th	68	Jonathan Bohmann	Southwest Research Institute	520	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Optimization of Next Generation Filovirus Therapeutics	Exhibit Hall D	View Abstract
Th	70	Victor Ogungbe	Jackson State University	539	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Investigation of non-structural protein 2 (nsp2) inhibitors as therapeutics for equine encephalitis and Chikungunya viral infections	Exhibit Hall D	View Abstract
W	71	Christopher Sumner	Sandia National Laboratory	548	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Characterization of SNL identified BBB-penetrating moieties (BBB PMs) for delivery of therapeutic cargo to the CNS	Exhibit Hall D	View Abstract
Th	72	Catalina Florez	USAMRIID	549	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Development of broad spectrum affinity matured monoclonal antibodies against New World Hantavirus	Exhibit Hall D	View Abstract
W	73	Amanda Phelps	DSTL	557	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Neurological sequelae – Assessing the hazard	Exhibit Hall D	View Abstract
W	75	LE THANH MAI PHAM	Sandia National Laboratories	604	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	DISCOVERY, DESIGN, AND ENGINEERING OF NANOBODY-BASED THERAPEUTICS FOR SARS-COV-2	Exhibit Hall D	View Abstract
Th	76	Rekha Panchal	USAMRIID	619	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	In vitro and in vivo evaluation of small molecule S-adenosylhomocysteinase (AHCY) inhibitor against Ebola virus	Exhibit Hall D	View Abstract
W	77	Steven Bradfute	University of New Mexico Health Sciences Center	624	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Long non-coding RNAs in Venezuelan Equine Encephalitis virus infection	Exhibit Hall D	View Abstract
Th	78	Caitlin Lehman	Virginia Tech	628	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Early growth response 1 (EGR1): A potential therapeutic target for encephalitic viral infections?	Exhibit Hall D	View Abstract
W	79	Olena Shtanko	Texas Biomedical Research Institute	632	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Development of small-molecule antivirals targeting host VPS34 complex for treatment of emerging virus threats	Exhibit Hall D	View Abstract
Th	80	Iris Jones	NTESS/Sandia National Laboratories	640	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	CRISPR inhibition and CRISPR activation pooled library screens offer an effective tool for identifying therapeutic targets against broad viral families	Exhibit Hall D	View Abstract
Th	81	Warren Hoeffler	HOF Therapeutics	645	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Repurposing catalytic inhibitors of topoisomerase cancer drugs as broad-spectrum countermeasures against viral and bacterial threats	Exhibit Hall D	View Abstract
Th	82	David Trudil	New Horizons Diagnostics Corp	664	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Treatment and Prevention of Respiratory Pathogens by use of a Modified Mannose Binding Lectin Based Aerosolized Nasal Spray	Exhibit Hall D	View Abstract
W	83	Sherine Abdelmawla	Akanocure Pharmaceuticals, Inc.	684	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	A Broad-Spectrum Antiviral and Immunomodulatory Agent Against COVID-19 And Disease-X	Exhibit Hall D	View Abstract
Th	84	Zachary Bornholdt	Eitr Biologics, Inc.	697	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	An orthogonal dual-interacting nanotherapeutic platform, ODIN, for the rapid development of broadly neutralizing multi-specific immunotherapeutics	Exhibit Hall D	View Abstract
W	85	Allen Duplantier	Latham BioPharm Group	716	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	A structure-based drug design approach to the discovery of inhibitors of alphavirus nsP2 helicase	Exhibit Hall D	View Abstract
Th	86	Elizabeth Clarke	University of New Mexico	725	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Iminosugars are broad-spectrum viral inhibitors	Exhibit Hall D	View Abstract
W	87	Jeff Hutchins	Inhalon Biopharma	738	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Development of a platform of broad-spectrum, inhalable immunobiologics for the prevention and treatment of emerging viral infections	Exhibit Hall D	View Abstract
Th	88	Blake Simmons	Lawrence Berkeley National Laboratory	743	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	A common structural framework for rapid therapeutic design against emerging pathogens	Exhibit Hall D	View Abstract
W	89	Herbert Schweizer	Northern Arizona University	101	Challenges Faced In The Planning, Deployment, And Adoption Of A Layered Medical Defense Strategy	Discovery of Burkholderia pseudomallei Bacteriophages that Mediate Antimicrobial Susceptibility through Efflux Pump Dependent Infection	Exhibit Hall D	View Abstract
Th	90	Beth Bachert	USAMRIID	333	Challenges Faced In The Planning, Deployment, And Adoption Of A Layered Medical Defense Strategy	Targeting the cell wall of Francisella: Peptidoglycan remodeling enzymes are essential for cell morphology and virulence, and show potential for therapeutic targeting	Exhibit Hall D	View Abstract
W	91	Sara Ruiz	USAMRIID	412	Challenges Faced In The Planning, Deployment, And Adoption Of A Layered Medical Defense Strategy	Characterization of a Cynomolgus Macaque Model of Q fever	Exhibit Hall D	View Abstract
Th	92	Erika Rapp	United States Military Academy	501	Challenges Faced In The Planning, Deployment, And Adoption Of A Layered Medical Defense Strategy	Combinations of novel bacteriophage are efficacious against MDR Pseudomonas aeruginosa and restore sensitivity to carbapenem antibiotics	Exhibit Hall D	View Abstract
W	93	Kevin Mlynek	USAMRIID	113	Combatting Emerging Biological Threats – Preparing for the Future Today	Biofilm as a predictor of attenuation in Francisella tularensis	Exhibit Hall D	View Abstract
Th	94	Patrick Armstrong	United States Military Academy	114	Combatting Emerging Biological Threats – Preparing for the Future Today	Investigation of Bacteriophage-Host Interactions Using Single Molecule Localization Microscopy	Exhibit Hall D	View Abstract
Th	96	Mary Hourihan	USAMRIID	139	Combatting Emerging Biological Threats – Preparing for the Future Today	Broad Spectrum Activity of Delafloxacin against Bacterial Biothreat Agents	Exhibit Hall D	View Abstract
W	97	Aysegul Nalca	U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)	152	Combatting Emerging Biological Threats – Preparing for the Future Today	Time to Protection Following Vaccination with JYNNEOS (IMVAMUNE/IMVANEX) and ACAM2000 against Lethal Monkeypox Virus in Nonhuman Primates	Exhibit Hall D	View Abstract
Th	98	Jonathan Allen	Lawrence Livermore National Laboratory	161	Combatting Emerging Biological Threats – Preparing for the Future Today	Using AI/ML models to learn molecular interactions for novel countermeasure design	Exhibit Hall D	View Abstract
W	99	Peter Barry	The Vaccine Group Ltd	184	Combatting Emerging Biological Threats – Preparing for the Future Today	Proof-of-concept for a transmissible Lassa virus vaccine in the rodent Mastomys natalensis reservoir: A strategy to mitigate spillover risk of highly pathogenic zoonotic viruses from animal reservoirs to humans	Exhibit Hall D	View Abstract
W	100	Nileena Velappan	Los Alamos National Laboratory	203	Combatting Emerging Biological Threats – Preparing for the Future Today	Multiscale Analytics for Pathogen Prediction	Exhibit Hall D	View Abstract
Th	102	Lloyd Hough	Department of Homeland Security Science and Technology Directorate	264	Combatting Emerging Biological Threats – Preparing for the Future Today	Hazard Awareness and Characterization Sciences to Protect the Homeland from Chemical, Biological, and Explosive Hazards	Exhibit Hall D	View Abstract
W	103	Shanna Ratnesar-Shumate	Department of Homeland Security Science and Technology Directorate	267	Combatting Emerging Biological Threats – Preparing for the Future Today	Establishment of a Collaborative Roadmap and Standard Protocol for Rapidly Assessing the Fate of Emergent Biological Agents in the Environment (FAtE)	Exhibit Hall D	View Abstract
Th	104	Simon D'oelsnitz	The University of Texas at Austin	268	Combatting Emerging Biological Threats – Preparing for the Future Today	Machine Learning Predictions of Antibody:Antigen Interactions	Exhibit Hall D	View Abstract
W	105	Brooke Ahern	U.S. Army DEVCOM Chemical Biological Center	269	Combatting Emerging Biological Threats – Preparing for the Future Today	GLADTIER: A high throughput analysis for characterizing toxin/receptor interactions for disruption or reversibility of toxin activity	Exhibit Hall D	View Abstract
Th	106	Joel Bozue	USAMRIID	282	Combatting Emerging Biological Threats – Preparing for the Future Today	Development, phenotypic characterization, genomic analysis, and virulence assessment of a Francisella tularensis panel for tularemia vaccine testing	Exhibit Hall D	View Abstract
W	107	Caroline Schuerger	Center for Security and Emerging Technology, Georgetown University	301	Combatting Emerging Biological Threats – Preparing for the Future Today	Using open source data to characterize and identify gaps in viral family research and medical countermeasures	Exhibit Hall D	View Abstract
Th	108	Chad Testa	Curza, Inc	307	Combatting Emerging Biological Threats – Preparing for the Future Today	Advancing CZ-02s (AIIPS) as a new class of medical countermeasure, with a new mechanism-of-action against drug-resistant bacterial infections, including those caused by multi-drug resistant Tier 1 Select Agents	Exhibit Hall D	View Abstract
W	109	Aarthy Vallur	InBios International Inc.	312	Combatting Emerging Biological Threats – Preparing for the Future Today	Passive concentration of Burkholderia pseudomallei capsular polysaccharide from melioidosis urine samples for the enhanced detection on the InBios Active Melioidosis DetectTM Lateral Flow Immunoassay	Exhibit Hall D	View Abstract
Th	110	Cassandra Smith Smith	MIT Lincoln Laboratory	325	Combatting Emerging Biological Threats – Preparing for the Future Today	National PPE Demand Estimate Tool	Exhibit Hall D	View Abstract
W	111	Austin Shapiro	DoN- NSWC Indian Head	346	Combatting Emerging Biological Threats – Preparing for the Future Today	Littoral river test planning tool	Exhibit Hall D	View Abstract
W	112	Aarthi Narayana	George Mason University	367	Combatting Emerging Biological Threats – Preparing for the Future Today	A DNA-nanoparticle-based antigen presenting platform for the development of broadly protective vaccines against acutely infectious viruses	Exhibit Hall D	View Abstract
W	113	Monica Borucki	Lawrence Livermore National Laboratory	381	Combatting Emerging Biological Threats – Preparing for the Future Today	Climate-driven Changes to Host Nutrition May Impact the Emergence and Phenotype of Viral Variants	Exhibit Hall D	View Abstract
Th	114	Amanda Love	JPEO-CBRND Medical	383	Combatting Emerging Biological Threats – Preparing for the Future Today	Vaccine Acceleration by Modular Progression (VAMP): Delivering Safe and Effective Vaccines to the Warfighter against New and Emerging Threats	Exhibit Hall D	View Abstract
W	115	Aykan Karabudak	Emergex USA	435	Combatting Emerging Biological Threats – Preparing for the Future Today	READI: an innovative synthetic T cell vaccine technology platform pairing a gold nanoparticle delivery system with select targets from a ligandome of prescreened pathogen derived, naturally processed & presented MHC-I peptides to provide rapid response solutions to combat and broadly protect against biothreat pathogens	Exhibit Hall D	View Abstract
Th	116	Migun Shakya	Los Alamos National Laboratory	446	Combatting Emerging Biological Threats – Preparing for the Future Today	Optimization and Development of Technologies for Environmental Biosurveillance	Exhibit Hall D	View Abstract
W	117	Denis Vashchenko	Lawrence Livermore National Lab	449	Combatting Emerging Biological Threats – Preparing for the Future Today	AbBERT: Learning Antibody Humanness via Masked Language Modeling	Exhibit Hall D	View Abstract
Th	118	Ian Gut	NBACC	469	Combatting Emerging Biological Threats – Preparing for the Future Today	Characterizing the lethal dose and disease progression of Bacillus cereus biovar anthracis Cameroon and Cote d'Ivoire following aerosol administration in the New Zealand white rabbit model.	Exhibit Hall D	View Abstract
W	119	Kenneth Carson	Southwest Research Institute	475	Combatting Emerging Biological Threats – Preparing for the Future Today	Advanced Development of Vaccines Against Francisella tularensis (Ft), a Category “A” Select Agent	Exhibit Hall D	View Abstract
Th	120	J. Matthew Meinig	USAMRIID	493	Combatting Emerging Biological Threats – Preparing for the Future Today	Enhanced in vitro activity of sodium fusidate against bacterial biothreat panels at low pH	Exhibit Hall D	View Abstract
W	121	Brianna Brasko	United States Military Academy	500	Combatting Emerging Biological Threats – Preparing for the Future Today	Bacteriophage for biothreat remediation against Bacillus anthracis	Exhibit Hall D	View Abstract
W	123	Armand Dichosa	Los Alamos National Laboratory	507	Combatting Emerging Biological Threats – Preparing for the Future Today	Genomics investigation of the human gut microbiome in microgravity using gel microdroplets and community cultivation strategies	Exhibit Hall D	View Abstract
Th	124	Anuj (AJ) Singhal	CFD Research	533	Combatting Emerging Biological Threats – Preparing for the Future Today	Extremophile Derived Natural Products (EDeN) to combat future threats	Exhibit Hall D	View Abstract
W	125	Richard Anthony	Vacunax Inc.	553	Combatting Emerging Biological Threats – Preparing for the Future Today	Superinfection Exclusion using Host Restricted-Live Attenuated Virus in persistently infected Mosquitoes as an Arbovirus Control Strategy	Exhibit Hall D	View Abstract
Th	126	Kelly Kim	Gryphon Scientific LLC.	560	Combatting Emerging Biological Threats – Preparing for the Future Today	Empirical Research in Biosafety	Exhibit Hall D	View Abstract
W	127	Armand Dichosa	Los Alamos National Laboratory	566	Combatting Emerging Biological Threats – Preparing for the Future Today	Supporting the development and evaluation of novel medical countermeasures by studying the emergence of single and multi-drug resistance in laboratory passed strains of Bacillus cereus	Exhibit Hall D	View Abstract
W	129	David Rozak	USAMRIID	581	Combatting Emerging Biological Threats – Preparing for the Future Today	Tracking the emergence and fate of antibiotic resistance mutations in heterogeneous Yersinia pseudotuberculosis cultures	Exhibit Hall D	View Abstract
Th	130	Анатолій Палій	NSC IECVM (Kharkiv, UA)	636	Combatting Emerging Biological Threats – Preparing for the Future Today	BIOTERRORISM LAUNCH FROM THE ACTS OF UNPUNISHED AGROTERRORISM	Exhibit Hall D	View Abstract
W	131	Chris Miller	SaNOtize Research & Development Corp.	637	Combatting Emerging Biological Threats – Preparing for the Future Today	Sanotize: Topical Nitric Oxide Nasal Spray to Prevent Viral Infections	Exhibit Hall D	View Abstract
Th	132	Warren Hoeffler	HOF Therapeutics	647	Combatting Emerging Biological Threats – Preparing for the Future Today	Harnessing the power of cell assembly programmed (CAP) organs: All organs samples available for threat assessment and regeneration as a countermeasure	Exhibit Hall D	View Abstract
Th	134	Anthony Gregory	University of California, Irvine	676	Combatting Emerging Biological Threats – Preparing for the Future Today	A cross-protective, multivalent mRNA vaccine against Burkholderia	Exhibit Hall D	View Abstract
W	135	Barney Bishop	George Mason University	689	Combatting Emerging Biological Threats – Preparing for the Future Today	Leveraging Natural Biodefense Mechanisms: Method Development for Host Defense Peptide Discovery	Exhibit Hall D	View Abstract
Th	136	Christina Gardner	USAMRIID	698	Combatting Emerging Biological Threats – Preparing for the Future Today	Does size matter? Examining virulence of eastern equine encephalitis virus in nonhuman primates exposed to small and large aerosol particles	Exhibit Hall D	View Abstract
W	137	James Nolan	Gryphon Scientific, LLC	719	Combatting Emerging Biological Threats – Preparing for the Future Today	An Integrated Machine Learning Approach to Constructing a Database of Biological Threat Actors	Exhibit Hall D	View Abstract
Th	138	Patrick Chain	Los Alamos National Laboratory	731	Combatting Emerging Biological Threats – Preparing for the Future Today	Impact of COVID-19 multi-lineage co-infections on consensus genomes & repository errors, and evidence of within-host recombination	Exhibit Hall D	View Abstract
Th	140	Blake Simmons	Lawrence Berkeley National Laboratory	744	Combatting Emerging Biological Threats – Preparing for the Future Today	Viral zoonoses and Human Adaptability - Integrating Multiomic Science with Machine Learning to Track Emergence	Exhibit Hall D	View Abstract
W	141	Olivia Holzhaus	Rhodium Scientific LLC	754	Combatting Emerging Biological Threats – Preparing for the Future Today	In Space Biomanufacturing: Establishing Scalable Point Source Production of Critical Compounds to Counter Biological Threats of the Future	Exhibit Hall D	View Abstract
Th	142	Helen Cui	Los Alamos National Laboratory	759	Combatting Emerging Biological Threats – Preparing for the Future Today	Global Scientific Engagement Enhancing Early Detection of Emerging Biological and Chemical Threats	Exhibit Hall D	View Abstract
W	143	Martin Pratt	Pacific Northwest National Laboratory	503	eXtended Reality for Chemical and Biological Defense in Tactical and Training Environments	Mixed Reality enhanced chemical detection with M8 paper using machine learning on Microsoft HoloLens	Exhibit Hall D	View Abstract
Th	144	Peter Anderson	MRIGlobal	527	eXtended Reality for Chemical and Biological Defense in Tactical and Training Environments	Augmented reality training for CBRN equipment	Exhibit Hall D	View Abstract
W	145	Andy Haefner	Gamma Reality Inc.	711	eXtended Reality for Chemical and Biological Defense in Tactical and Training Environments	Multi-sensor Data Fusion and Visualization of CBRN Threats in Augmented Reality	Exhibit Hall D	View Abstract
W	147	Richard Kingsborough	MIT	133	From Sensing To Making Sense	Low-SWaP-C Colorimetric Detection of Vapor-Phase Chemical Threats	Exhibit Hall D	View Abstract
Th	148	Joshua Uzarski	US Army DEVCOM Soldier Center	154	From Sensing To Making Sense	Development of a machine learning-enabled multiplexed chemical warfare agent detection system	Exhibit Hall D	View Abstract
Th	150	Patrick Riley	U.S. Army DEVCOM Chemical Biological Center	170	From Sensing To Making Sense	Unsupervised Spectral Compression	Exhibit Hall D	View Abstract
W	151	William Harrison	NanoSonic Inc	492	Protection - Science and Technology Advances for Chemical and Biological Protection	High Stretch, Environmentally Robust, Elastomeric Barrier Composite for CBRN Protective Ensembles	Exhibit Hall D	Abstract unavailable.
Th	152	Sarah Dowling	Indiana University Purdue University Indianapolis	181	From Sensing To Making Sense	Leveraging the diverse power of mass spectrometry for simplified threat agent sensing	Exhibit Hall D	View Abstract
W	153	Andres Gaviria-Figueroa and Erin McAuley	Booz Allen Hamilton	194	From Sensing To Making Sense	Genomic Wastewater Surveillance for Infectious Disease Monitoring	Exhibit Hall D	View Abstract
Th	154	Erik Emmons	US Army DEVCOM CBC	202	From Sensing To Making Sense	Waveguide-Enhanced Raman Spectroscopy for Field Detection of Threat Materials	Exhibit Hall D	View Abstract
Th	156	Rebecca Hutchins	GTRI	217	From Sensing To Making Sense	Edge computing for global genomics-based threat detection, assessment, and decision support	Exhibit Hall D	View Abstract
W	157	Elizabeth Dhummakupt	US Army DEVCOM Chemical Biological Center	239	From Sensing To Making Sense	Sticking It to Collection and Analysis: Utilizing Pressure-Sensitive Adhesive Paper Combined with Portable Mass Spectrometry for Detection of Threats	Exhibit Hall D	View Abstract
Th	158	Natalie Gese	Washington State University	240	From Sensing To Making Sense	Reference Spectra for the Identification of Chemical Warfare Agent Simulants	Exhibit Hall D	View Abstract
W	159	Radislav Potyrailo	GE Research	273	From Sensing To Making Sense	Delivering low-false-alarm multi-gas sensing performance in pervasive applications by cross-pollination between sensor electronics and mathematics of traditional analytical instruments	Exhibit Hall D	View Abstract
W	161	Joseph Russell	MRIGlobal	299	From Sensing To Making Sense	Field-Forward Threat Sensing Through Raw Nanopore Electrical Signal: A Case Study in Arthropod-Borne Pathogen Detection on Saint Catherines Island	Exhibit Hall D	View Abstract
Th	162	Robert Short	Detect-Ion	336	From Sensing To Making Sense	Micro Mass Spectrometry for enabling a Fieldable, High-Accuracy, Chemical Threat Sensing	Exhibit Hall D	View Abstract
W	163	Mitch Wells	Teledyne FLIR Detection, Inc.	342	From Sensing To Making Sense	Two-dimensional Tandem Mass Spectrometry (2D MS/MS) for enhanced target detection and identification on a field-confirmatory portable mass spec system	Exhibit Hall D	View Abstract
Th	164	Elisabeth Koplar	Spectra Plasmonics	349	From Sensing To Making Sense	From illicit-drug identification to chemical warfare combat: Fully Portable SERS technology for the rapid and accurate identification of chemical compounds	Exhibit Hall D	View Abstract
W	165	Peter Mantica	ARA	350	From Sensing To Making Sense	Description and Utility of the Chemical/Biological System of Systems Optimization Tool (CBSoSOT)	Exhibit Hall D	View Abstract
Th	166	Angela Zeigler	U.S. Army DEVCOM Chemical Biological Center	354	From Sensing To Making Sense	Paper on Demand: Inkjet Printing of Task-Specific Assays	Exhibit Hall D	View Abstract
W	167	William Lawrence	MIT Lincoln Laboratory	382	From Sensing To Making Sense	Standoff Snapshot Spectral Sensor for UAV based Chemical Vapor Sensing	Exhibit Hall D	View Abstract
Th	168	Johannes Langenberg	TNO Defence, Safety and Security	388	From Sensing To Making Sense	Early detection and differential diagnosis of acute chemical intoxications using AI	Exhibit Hall D	View Abstract
W	169	David Glasbrenner	Battelle Memorial Institute	407	From Sensing To Making Sense	Bioperception Digital Engineering (BRDGE): A biodetection implementation and scenario modeling evaluation tool	Exhibit Hall D	View Abstract
Th	170	J. Andrew Kouzelos	Design West Technologies, Inc.	415	From Sensing To Making Sense	Wearable Chemical Detector for Aerosolized Threats	Exhibit Hall D	View Abstract
W	171	Eric Meshot	Lawrence Livermore National Laboratory	440	From Sensing To Making Sense	A Chemically Programmable Nano-Electronic Nose for Multi-Threat Detection	Exhibit Hall D	View Abstract
Th	172	Alexander Govorov	Ohio University, Athens	477	From Sensing To Making Sense	Plasmonic paper-based sensing of small CWA molecules	Exhibit Hall D	View Abstract
W	173	Ben Gardner	Collins Aerospace	509	From Sensing To Making Sense	UAV-based optical standoff identification capability	Exhibit Hall D	View Abstract
W	174	Armand Dichosa	Los Alamos National Laboratory	510	From Sensing To Making Sense	Preparing for the Next Pandemic: Impact of Thawing Permafrost for Ancient Pathogens	Exhibit Hall D	View Abstract
W	175	Euan McLeod	University of Arizona	514	From Sensing To Making Sense	Microtoroid optical chemosensors augmented with nanostructures for mechanically robust and stable sensing	Exhibit Hall D	View Abstract
Th	176	Judith Su	University of Arizona	519	From Sensing To Making Sense	Ultra-sensitive and selective chemical threat sensing microtoroid resonators	Exhibit Hall D	View Abstract
W	177	Olga Baturina	Naval Research Laboratory	523	From Sensing To Making Sense	Detection of Dimethyl Methyl Phosphonate (DMMP) by Acetylcholinesterase (AChE)-Grafted Plasmonic Sensor	Exhibit Hall D	View Abstract
Th	178	Maulik Kotecha	J. Mike Walker ’66 Department of Mechanical Engineering, Texas A&M University	537	From Sensing To Making Sense	Extending The Diagnostic Capabilities of AI-based Portable MIMS-Systems for The Identification of Breath VOCs and Passive Sensing Applications	Exhibit Hall D	View Abstract
W	179	Jeremy Wright	Sandia National Laboratories	545	From Sensing To Making Sense	Real-time In-situ Plume Characterization	Exhibit Hall D	View Abstract
Th	180	Bradley Abramson	Noblis	589	From Sensing To Making Sense	Portable Sequencing Plus	Exhibit Hall D	View Abstract
W	181	Joshua Whiting	NTESS	593	From Sensing To Making Sense	Building On Fentanyl Analog Independent Detection (FAID) for Other Novel Challenges	Exhibit Hall D	View Abstract
Th	182	Michael Oglesbee	The Ohio State University, Infectious Diseases Institute	595	From Sensing To Making Sense	Leading not Bleeding: A Model for Innovation in a Clinical Diagnostic Laboratory Providing Real-time Public Health Surveillance Data	Exhibit Hall D	View Abstract
W	183	Jessica Milke	Teledyne FLIR Detection, Inc.	615	From Sensing To Making Sense	Systems engineering approach to designing a low SWaP multi-class chemical vapor detector to address warfighter needs in the early development phase	Exhibit Hall D	View Abstract
Th	184	Matthew Aernecke	908 Devices	660	From Sensing To Making Sense	The Aero – A capability to rapidly detect aerosolized threats in the field	Exhibit Hall D	View Abstract
W	185	Carolyn Cramer	Pacific Northwest National Laboratory	675	From Sensing To Making Sense	Chemical Biological Defense Application Development Internship Competition	Exhibit Hall D	View Abstract
Th	186	Dave Roberts	National Strategic Research Institute	701	From Sensing To Making Sense	Towards Early Warning via Advanced Biological Sampling Efforts (Project ATREYU), An Automatic Biological Collection and PCR-identification System for Remote Sensing	Exhibit Hall D	View Abstract
W	187	Stephen Houghton	SRC, Inc	704	From Sensing To Making Sense	ML-based Classification of CB Containing Munitions or Drones by Radar for Integrated Early Warning	Exhibit Hall D	View Abstract
Th	188	Oliver Nakano-Baker	University of Washington	707	From Sensing To Making Sense	Rapidly deployable, compact detection platform using computationally designed molecular probes for disease, performance, and evolving threats	Exhibit Hall D	View Abstract
W	189	Jeff Pruitt	S3	720	From Sensing To Making Sense	Improved Standoff Threat Detection and Situational Awareness Using Multimodal Lidar-ASI System	Exhibit Hall D	View Abstract
Th	190	Won Kim	Draper	79	From Sensing To Making Sense	Fully Autonomous Aeral Chemical Plume Mapping	Exhibit Hall D	View Abstract
W	191	Robert Cubeta	IDA	82	From Sensing To Making Sense	Biological Warfare Agent Clinical Sampling and Analysis: Opportunities and Limitations	Exhibit Hall D	View Abstract
Th	192	Kerry Vahala	California Institute of Technology	88	From Sensing To Making Sense	Towards miniature dual-comb spectroscopy systems for mid-IR trace gas sensing	Exhibit Hall D	View Abstract
W	193	Ian Pardoe	U.S. Army DEVCOM Chemical Biological Center	95	From Sensing To Making Sense	Versatile materials for wide-ranging applications of colorimetric and electronic detection of chemical warfare agents	Exhibit Hall D	View Abstract
Th	194	Nathan McDonald	U.S. Army DEVCOM Chemical Biological Center	221	Genetic Engineering Technologies and Detection of Gene Editing	Assessing functionality of cell-free protein systems from traditional biothreat organisms	Exhibit Hall D	View Abstract
W	195	Natalie Robinett	Excet support to U.S. Army DEVCOM Chemical Biological Center	226	Genetic Engineering Technologies and Detection of Gene Editing	Building genes from scratch: A cost and time assessment of novel enzymatic DNA synthesis technology (Abstract for CBS, Roman Hernandez)	Exhibit Hall D	View Abstract
Th	196	Casey Bernhards	U.S. Army DEVCOM Chemical Biological Center	347	Genetic Engineering Technologies and Detection of Gene Editing	Determining the prevalence of CRISPR off-target effects in bacteria: Can we detect if an organism has been genetically engineered?	Exhibit Hall D	View Abstract
W	197	Tiffany Bernardo	MilliporeSigma	365	Genetic Engineering Technologies and Detection of Gene Editing	The Swiss Army Knife of Genome Engineering: A Brief History, Mechanistic Overview, and Current Applications of CRISPR Technology	Exhibit Hall D	View Abstract
W	198	Cory Bernhards	U.S. Army DEVCOM Chemical Biological Center	402	Genetic Engineering Technologies and Detection of Gene Editing	Detecting genetic engineering via portable nanopore sequencing and reachback data analysis tools	Exhibit Hall D	View Abstract
W	199	Nicholas Roehner	Raytheon BBN Technologies	488	Genetic Engineering Technologies and Detection of Gene Editing	Use of a Biological Decompiler to Predict Engineered Phenotype from Genomic Sequence Data	Exhibit Hall D	View Abstract
Th	200	Mike Farrell	Georgia Tech Research Institute	108	Harnessing Physiological Data for Early Warning of Threat Exposure	Population-based fever surveillance for early warning of infectious disease outbreaks.	Exhibit Hall D	View Abstract
W	201	Christopher Katinas	Sandia National Laboratories	131	Harnessing Physiological Data for Early Warning of Threat Exposure	Remote detection of human vital signs via hyperspectral and multispectral images	Exhibit Hall D	View Abstract
Th	202	Consuelo Cuevas	MIT Lincoln Laboratory	378	Harnessing Physiological Data for Early Warning of Threat Exposure	Model-Agnostic Framework for Evaluating Performance, Robustness, and Fairness of Machine Learning Infection Detection	Exhibit Hall D	View Abstract
W	203	Matthew Lux	U.S. Army DEVCOM Chemical Biological Center	521	Harnessing Physiological Data for Early Warning of Threat Exposure	Predicting Disease Outcomes From Physiological Data In The Common Marmoset	Exhibit Hall D	View Abstract
Th	204	Jane Valentine	Johns Hopkins University Applied Physics Laboratory	534	Harnessing Physiological Data for Early Warning of Threat Exposure	Modeling detection of anthrax outbreak onset via a novel human sentinel network	Exhibit Hall D	View Abstract
W	205	Meghan Hegarty-Craver	RTI International	606	Harnessing Physiological Data for Early Warning of Threat Exposure	Real-Time CBRN Algorithms Using Smartwatch Data	Exhibit Hall D	View Abstract
Th	206	David Noren	Philips Research	653	Harnessing Physiological Data for Early Warning of Threat Exposure	Developing predictive models of chemical hazard exposure with hospital data: a case study using opioid treatment	Exhibit Hall D	View Abstract
W	207	Sara Mariani	Philips Research	670	Harnessing Physiological Data for Early Warning of Threat Exposure	Monitoring Exposure through Standoff Health	Exhibit Hall D	View Abstract
Th	208	Jaques Reifman	U.S. Army Medical Research and Development Command	86	Harnessing Physiological Data for Early Warning of Threat Exposure	Wearables detect malaria early in a controlled human-infection study	Exhibit Hall D	View Abstract
W	209	Stephen Davis	Battelle Memorial Institute	115	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Chemical Fires Module Prototype II	Exhibit Hall D	View Abstract
W	211	Maria Bauer	DWT	141	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	SwarmPuck - Drone Swarm enabled CBRN sensing	Exhibit Hall D	View Abstract
Th	212	Nathan Platt	IDA	151	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Operationally Relevant Methodology for the Evaluation of Inhalation Hazard Resulting from Chemical Warfare Agent Secondary Evaporation	Exhibit Hall D	View Abstract
Th	214	Steven Kennon	Valent Applications Ltd	164	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Development of an agnostic UGV adapter for the remote characterisation & disposal of CB threats in sealed CBRN devices	Exhibit Hall D	View Abstract
W	215	Charles Lissandrello	Draper	191	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Microfluidic innovations to enable sensitive and multiplexed nucleic acid detection in the field	Exhibit Hall D	View Abstract
Th	216	Michal Simko	SEC Technologies, s.r.o.	252	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	LIDAR based CWA stand-off detector using 2 CO2 tuneable laser under real-life scenarios	Exhibit Hall D	View Abstract
W	217	Matthew Moe	DHS S&T	275	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	DHS S&T CBRN hazard assessment challenges and opportunities	Exhibit Hall D	View Abstract
W	219	Jordan Lefebvre	Aeris LLC	355	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Tactical Assault Kit Tactical Sensor Placement (TAK TSP)	Exhibit Hall D	View Abstract
Th	220	Jerry Cabalo	DHS-S&T-CSAC	358	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Microsensor Arrays (e-Noses) for Food Defense	Exhibit Hall D	View Abstract
W	221	Cody Floerchinger	Aeris LLC	408	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Microscale Urban Transport and Dispersion Modeling with the Joint Outdoor-Indoor Urban Large Eddy Simulation (JOULES)	Exhibit Hall D	View Abstract
Th	222	Heesoo Jung	Agency for Defense Development, South Korea	455	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Dynamic and static evaporation of chemical warfare agent Novichok on the various materials	Exhibit Hall D	View Abstract
W	223	Jason Han	MIT Lincoln Laboratory	461	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Characterization of Illicit Synthetic Opioid-Based Threat Scenarios in Support of Physical Modeling and Hazard Prediction	Exhibit Hall D	View Abstract
Th	224	Joseph P. Smith	Oceanography Department, U.S. Naval Academy	496	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Improvement of Model Predictions for Waterborne Hazard Fate and Transport and the Development of Autonomous Surface Platforms for ‘Smart’ Chemical Plume Tracking in Coastal Systems	Exhibit Hall D	View Abstract
W	225	Henry Lau	MIT Lincoln Laboratory	499	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Supporting mission planning and course of action evaluation using MEURIADS and DEMASQ	Exhibit Hall D	View Abstract
Th	226	Ryan Hafer	Applied Research Associates	532	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Reconnaissance and Surveillance Planning and Offroad Routing with CB Hazards at the Tactical Edge	Exhibit Hall D	View Abstract
Th	227	Ryan Hafer	Applied Research Associates	535	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Integrating Situation Awareness with Mission Analysis of CB Protection at the Tactical Level	Exhibit Hall D	View Abstract
W	229	Chika Igba	USAMRIID	561	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Genotypic and phenotypic analysis of 22 historic Francisella tularensis isolates available through the Biodefense Reference Material Repository	Exhibit Hall D	View Abstract
Th	230	Jacob Beal	Raytheon BBN	562	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	FAST-NA Scanner: high-speed, low-SWaP computational assessment of biological threats	Exhibit Hall D	View Abstract
W	231	Michael Sohn	Lawrence Berkeley National Laboratory	623	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Integrated Urban: Progress and vision for an urban hazard assessment capability	Exhibit Hall D	View Abstract
W	233	Erin Linebarger	Neya Systems	678	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Multi-vehicle mission management for autonomous robotic CBRN response in ATAK	Exhibit Hall D	View Abstract
Th	234	Mark Blenner	University of Delaware	691	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Leveraging the Outdoor and Built Environment Microbiota for Threat Signature Detection and Decision Support	Exhibit Hall D	View Abstract
Th	236	Jason Byrd	ENSCO, Inc	729	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Rapid estimation of chemical properties with PRESTO	Exhibit Hall D	View Abstract
W	237	Mian Jiang	University of Houston-Downtown	756	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Field assembling of portable batteries based on conventionally accessible material for sustainable and versatile applications in battleground	Exhibit Hall D	View Abstract
Th	238	Derrick Kaseman	Los Alamos National Laboratory	757	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	Earth’s field nuclear magnetic resonance: A new fieldable spectroscopy for organophosphate detection	Exhibit Hall D	View Abstract
W	239	Eric Hugues	Telops	83	Innovations In Next Generation CB Threat Characterization And Assessment For Decision Support	The Hyper-Cam Nano: the next-generation thermal infrared hyperspectral imaging system.	Exhibit Hall D	View Abstract
Th	240	Shane Kasten	USAMRICD	109	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	SkinKast: A multi-modal dermal disclosure spray for the rapid detection of chemical warfare agents on intact skin	Exhibit Hall D	View Abstract
W	241	Bruce Salter	AFCEC	124	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Physical and Chemical Performance Evaluation of an Alumina-Based Sorbent Kit after Expiration	Exhibit Hall D	View Abstract
Th	242	Dimiter Petsev	University of New Mexico	179	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Modeling of binary droplets impacting and contacting surfaces	Exhibit Hall D	View Abstract
W	243	Janlyn Eikenberg	U.S. Army DEVCOM Chemical Biological Center	223	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	The effects of dirtied surfaces on contaminant retention and decontaminant performance	Exhibit Hall D	View Abstract
Th	244	Joseph Myers	U.S. Army DEVCOM Chemical Biological Center	225	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Chemical Hot Air Decontamination of contaminants from military relevant materials and sensitive electronic equipment using elevated relative humidity	Exhibit Hall D	View Abstract
W	245	Harold Barnette	Naval Surface Warfare Center-Dahlgren Division	247	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Dew point modeling the inactivation of Bacillus anthracis and B. thuringiensis spores, and an enveloped ribonucleic acid (RNA) virus surrogate for SARS-CoV-2 is a new tool for hot, humid air decontamination	Exhibit Hall D	View Abstract
Th	246	Tony Buhr	Naval Surface Warfare Center-Dahlgren	248	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Ultraviolet dosage and decontamination efficacy was widely variable across 14 UV devices after testing a dried enveloped ribonucleic acid virus surrogate for SARS-CoV-2	Exhibit Hall D	View Abstract
W	247	Alice Young	Naval Surface Warfare Center-Dahlgren	254	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	pH-adjusted bleach shelf-life testing demonstrated decontamination efficacy on a non-porous material contaminated with Bacillus anthracis Sterne and Ames spores for up to 13 weeks	Exhibit Hall D	View Abstract
W	248	Melissa Sweat	DTRA	256	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Evaluation of polymer-penetrant interactions to elucidate contaminant uptake and retention in polymer coatings	Exhibit Hall D	View Abstract
W	249	Vipin Rastogi	U.S. Army DEVCOM Chemical Biological Center	260	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Effective and Rapid Canine skin Disinfection	Exhibit Hall D	Abstract unavailable.
Th	250	Robert Zimmerman	NSWC Indian Head, Navy Chem Bio Defense Div. (R2)	261	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Purple Haze: A rapid, energetics based solution for biological agent defeat	Exhibit Hall D	View Abstract
W	251	Vipin Rastogi	U.S. Army DEVCOM Chemical Biological Center	262	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Disinfection of Surfaces Contaminated with SARS-CoV-2 Surrogate, HuCoV229E	Exhibit Hall D	View Abstract
W	253	Anthony Malanoski	Naval Research Laboratory	274	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Assessing Chemical Protective Capabilities in Coating Technologies	Exhibit Hall D	View Abstract
W	255	Sun Dal Kim	Agency for Defense Development	319	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Comparison of Decontamination Rates and Products of Chemical Agents Through Reaction with Various Homogeneous Solutions	Exhibit Hall D	View Abstract
Th	256	Jana Kesavan	U.S. Army DEVCOM Chemical Biological Center	335	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Evaluation of cold weather decontamination methods	Exhibit Hall D	View Abstract
W	257	David McGarvey	U.S. Army DEVCOM Chemical Biological Center	389	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	HR-MAS analysis of skin exposed to chemical warfare agents	Exhibit Hall D	View Abstract
W	258	Igor Novosselov	University of Washington	392	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Supercritical Water Oxidation of Chemical Warfare Agents and Surrogates	Exhibit Hall D	View Abstract
W	259	Valentine Nzengung	MuniRem Environmental LLC	397	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Development, Evaluation, and Optimization of a Chemical Decontaminant for Chemical Warfare Agents	Exhibit Hall D	View Abstract
Th	260	Shannon Niehus	Archival Institute	399	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Using Underwater Drones to Mitigate Waterborne CBRN Threats	Exhibit Hall D	View Abstract
W	261	Olga Baturina	Naval Research Laboratory	401	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Nano structured titanium oxide materials capable of effective heterogeneous reactivity with 2-ethyl ethyl sulfide under ambient conditions	Exhibit Hall D	View Abstract
Th	262	David Jiang	UCLA Chemical and Biomolecular Engineering Department	422	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Dehydrochlorination decomposition of sulfur mustard and 2-CEES on rutile-TiO2(110): A DFT study	Exhibit Hall D	View Abstract
W	263	Brady Gentle	Defence Science and Technology Group	445	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Decontamination of ricin and abrin with detection by quantitative activity assay	Exhibit Hall D	View Abstract
Th	264	Zachary Minter	National Strategic Research Institute (NSRI)	464	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Rapid Energetic Medical Instrument Sterilization (REMIS)	Exhibit Hall D	View Abstract
W	265	Brent Mantooth	U.S. Army DEVCOM Chemical Biological Center	486	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Understanding and Controlling Chemical Transport in Coatings	Exhibit Hall D	View Abstract
Th	266	John Landers	Leidos support to U.S. Army DEVCOM Chemical Biological Center	517	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	All-Weather Dry Decontaminant Fibers for HD Degradation	Exhibit Hall D	View Abstract
W	267	Mihee Kim	Los Alamos National Laboratory	641	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Reduction of Bacterial Adhesion by Self-Assembled Coatings of Zwitterionic Sulfobetaine-Containing Brush Polymers	Exhibit Hall D	View Abstract
Th	268	Lim Ji Won	Agency for Defense Development	642	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Characterization of a continuous neutralization for the chemical warfare agents by a flow reactor	Exhibit Hall D	View Abstract
W	269	Jihyun Kwon	Agency for Defense Development	650	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Neutralization rates and enthalpy of simulants and GD for disposal of the chemical warfare agents	Exhibit Hall D	View Abstract
Th	270	Robert diTargiani	US Army Medical Research Institute of Chemical Defense	668	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Wound Decontamination Evaluation Pipeline (WDEP): Decontamination of wounds contaminated with chemical warfare agents.	Exhibit Hall D	View Abstract
Th	272	Ketan Bhatt	CFD Research Corporation	750	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Portable Cold Plasma System for Microbial Decontamination	Exhibit Hall D	View Abstract
W	273	Eva Lee	Designing an Unmanned System to Protect Warfighters and Civilians During WMD Attacks	758	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Protecting warfighters (and civilians) during WMD attacks	Exhibit Hall D	View Abstract
Th	274	Charles Carfagna, Jr.	Luna Labs USA	765	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Durable Self-Decontaminating Solgel Coatings	Exhibit Hall D	View Abstract
W	275	Lawrence Dubois	Nanoionix, LLC	89	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Tough, permanent self-decontaminating paints and coatings for defense applications	Exhibit Hall D	View Abstract
Th	276	Brian France	TDA Research, Inc.	97	Mitigation - Science and Technology Advances for Chemical and Biological Contamination Mitigation	Development of a Field Decontamination Kit for Military Working Dogs	Exhibit Hall D	View Abstract
W	277	Johanna Bobrow	MIT Lincoln Laboratory	125	Next-Generation Bioaerosol Detection & Identification	Rapid Fieldable Biothreat Identification Via Laser-Based PCR	Exhibit Hall D	View Abstract
Th	278	Matt O'Neal	NSWC Indian Head Division	362	Bio-Fi: Leveraging the Power of Biological Big Data for Advanced Analytics and Modeling of Chemical and Biological Threats	US Navy Shipboard Performance Model Approach to Empowering the Warfighter	Exhibit Hall D	View Abstract
W	279	Jamie Marsay	Kromek	193	Next-Generation Bioaerosol Detection & Identification	Kromek Automated Pathogen Scanner - Air Sequencing (KAPscan-AS): Agnostic airborne pathogen detection and identification via fully automated and autonomous Long Read Sequencing	Exhibit Hall D	View Abstract
Th	280	Bryan Rivers	U.S. Army DEVCOM Chemical Biological Center	228	Next-Generation Bioaerosol Detection & Identification	Assay and sample preparation method development for the Extreme PCR Bio-ID Rapid Detector (xBIRD) prototype	Exhibit Hall D	View Abstract
W	281	Anastasios Chanalaris	Kromek	271	Next-Generation Bioaerosol Detection & Identification	Zoonotic and Engineered Pathogen Identification from Metagenomic Reads	Exhibit Hall D	View Abstract
W	283	Michael Brothers	Air Force Research Laboratory 711th Human Performance Wing/UES Inc.	387	Next-Generation Bioaerosol Detection & Identification	Development of Micro-fluidic Capability for Rapid Environmental Bioreconnaissance Point Sensor Targeting Biological Threats	Exhibit Hall D	View Abstract
Th	284	Vishaka Santosh	Excet support to U.S. Army DEVCOM Chemical Biological Center	393	Next-Generation Bioaerosol Detection & Identification	Rapid and automated identification of aerosolized biothreats	Exhibit Hall D	View Abstract
W	285	Cory Bernhards	U.S. Army DEVCOM Chemical Biological Center	396	Next-Generation Bioaerosol Detection & Identification	Bioaerosol threat surveillance via untargeted nanopore sequencing technology	Exhibit Hall D	View Abstract
Th	286	Ethan McBride	Los Alamos National Laboratory	404	Next-Generation Bioaerosol Detection & Identification	Multi-dimensional Portable Mass Spectrometry for Biological Detection	Exhibit Hall D	View Abstract
W	287	Adina Doyle	U.S. Army DEVCOM Chemical Biological Center	424	Next-Generation Bioaerosol Detection & Identification	Biodiversity of the operational aerosol background environment	Exhibit Hall D	View Abstract
Th	288	Mike Farrell	Georgia Tech Research Institute	443	Next-Generation Bioaerosol Detection & Identification	Next Generation Biosensor	Exhibit Hall D	View Abstract
W	289	Miles Rogers	Raytheon BBN Technologies	490	Next-Generation Bioaerosol Detection & Identification	A Surface Acoustic Wave Immunosensor for Aerosol Detection	Exhibit Hall D	View Abstract
Th	290	Daniel Lauriola	BaySpec, Inc.	515	Next-Generation Bioaerosol Detection & Identification	Detection and identification of bioaerosol species by miniaturized Dual Frequency Combs based waveguide enhanced Coherent Raman Spectroscopy (DC-WECRS)	Exhibit Hall D	View Abstract
W	291	Eric Carnes	University of Nebraska Medical Center	601	Next-Generation Bioaerosol Detection & Identification	Stabilization of Critical Reagents for Cold-Chain-Free Global Deployment	Exhibit Hall D	View Abstract
Th	292	Patricia Buckley	U.S. Army DEVCOM Chemical Biological Center	658	Next-Generation Bioaerosol Detection & Identification	Biothreat Detection Canines for Disease Detection and Pandemic Preparedness	Exhibit Hall D	View Abstract
W	293	Kevin Crown	National Strategic Research Institute	710	Next-Generation Bioaerosol Detection & Identification	Rapidly dissolvable filters for biological aerosol collection with high collection efficiency, 100% extraction efficiency, and maintenance of viability for down-stream analysis and inclusion into automatic microfluidic identification	Exhibit Hall D	View Abstract
Th	294	Trina Vian	MIT Lincoln Laboratory	85	Next-Generation Bioaerosol Detection & Identification	Chemical and biological agent defense in subways	Exhibit Hall D	View Abstract
W	295	Daniel Angelini	U.S. Army DEVCOM Chemical Biological Center	231	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Multiomic analysis of vesicant exposed human dermal equivalent	Exhibit Hall D	View Abstract
Th	296	Gabrielle Rizzo	US Army DEVCOM Chemical Biological Center	233	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Normalization of organ-on-a-chip samples for mass spectrometry-based proteomics and metabolomics via dansylation-based assay	Exhibit Hall D	View Abstract
W	297	Dylan Fudge	DTRA	270	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Design and Application of an Adept Aerosol/Vapor Lung-on-Chip and Aerosol/Vapor Delivery Systems	Exhibit Hall D	View Abstract
Th	298	Christopher Phillips	U.S. Army DEVCOM Chemical Biological Center	285	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	The use of the 6DPF larval zebrafish in a light dark behavioral assay to determine the sub-lethal effects of Dexmedatomidine, Carfentanil, Ketamine, and VX.	Exhibit Hall D	View Abstract
W	299	Nick Fischer	Lawrence Livermore National Lab	359	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	RECAPITULATING COMPLEX NEURONAL-GLIA NETWORKS IN AN IN VITRO SYSTEM FOR TOXICANT CHARACTERIZATION	Exhibit Hall D	View Abstract
Th	300	Claire Robertson	Lawrence Livermore National Lab	395	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Bioprinted functional human vasculature to study mechanisms of vasculitis	Exhibit Hall D	View Abstract
W	301	Trevor Glaros	LANL	414	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	InCEPTIoN: Integrated OmiCs of Emergent Pathways for Therapeutic Intervention of New and Emerging Threats	Exhibit Hall D	View Abstract
Th	302	Martin Trapecar	Johns Hopkins University School of Medicine	587	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Donor-matched Multiorgan Microphysiological Systems in Advanced Risk Assessment	Exhibit Hall D	View Abstract
W	303	Lenka Pulkrabkova	Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove (Czech Republic)	596	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	IN VITRO MODEL EXPRESSING ACETYLCHOLINESTERASE FOR THE EVALUATION OF NEUROTOXICITY AND PROTECTION AGAINST NERVE AGENTS	Exhibit Hall D	View Abstract
Th	304	Warren Hoeffler	HOF Therapeutics	646	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Cryopreservation improvements for CAP organs-on-chip increase viability and reproducibility to improve data sets on CB threats and counter measure development	Exhibit Hall D	View Abstract
W	305	Nicholas Be	Lawrence Livermore National Laboratory	677	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Microbiome platforms for prediction of human health and threat resilience	Exhibit Hall D	View Abstract
Th	306	Mohammad Omar Ishak	Los Alamos National Laboratory	735	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	In-vitro 3D skin model with applications in biodosimetry & toxicology	Exhibit Hall D	View Abstract
W	307	Heath Mills	Rhodium Scientific LLC	752	Overcoming Limitations of Organ-on-Chip (OoC) Technologies to Advance the Characterization and Medical Management of Chemical and Biological (CB) Threats	Establishing an Astronaut Gut on a Chip to Develop Countermeasures against Gut Microbiome Dysbiosis in Space	Exhibit Hall D	View Abstract
W	309	Joseph Eiden	FluGen	182	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Intranasal M2SR (M2-deficient single replication) live H3N2 investigational influenza vaccine induces HAI responses against drifted influenza strains, as well as T cell responses and mucosal IgA in serosusceptible adults	Exhibit Hall D	View Abstract
Th	310	Sergei Biryukov	USAMRIID	212	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Protective Efficacy and Immune Response of Subunit Hcp1-based and Live Attenuated Bp 668 ΔilvI Candidate Vaccines	Exhibit Hall D	View Abstract
W	311	Apichai Tuanyok	Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL	303	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Burkholderia pseudomallei Infection Models in Humanized HLA Transgenic Mice	Exhibit Hall D	View Abstract
Th	312	Jennifer Schwedler	Sandia National Labs	305	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Therapeutic efficacy of a potent anti-VEEV antibody is contingent on humoral and cell-mediated cytotoxic immunity	Exhibit Hall D	View Abstract
W	313	Riccardo d'ELia	Defence Science and Technology Laboratory UK	320	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Plague RNA vaccine efficacy in the mouse model	Exhibit Hall D	View Abstract
W	315	Paul Brett	University of Nevada, Reno School of Medicine	366	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Development of scalable processes to facilitate GMP‐compliant production of a melioidosis subunit vaccine candidate	Exhibit Hall D	View Abstract
Th	316	Mary Burtnick	University of Nevada, Reno School of Medicine	368	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Optimization of serological assays for the analysis of antigen-specific antibody responses in melioidosis patients	Exhibit Hall D	View Abstract
W	317	Joshua Dye	Darwin Biosciences, Inc.	376	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Designing studies for the collection and analysis of saliva samples from pre-symptomatic individuals	Exhibit Hall D	View Abstract
Th	318	Michael Norris	University of Florida Emerging Pathogens Institute	405	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Inability to synthesize anthrose leads to pathophysiological changes in Bacillus anthracis.	Exhibit Hall D	View Abstract
Th	319	Michael Norris	University of Florida Emerging Pathogens Institute	409	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Identification of new host-interactomes during cellular anthrax	Exhibit Hall D	View Abstract
Th	320	Ann Sluder	Massachusetts General Hospital	410	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Longitudinal study of immune responses to Q-VAX in young healthy adults to support the development of novel vaccines for Q fever and tests for exposure surveillance	Exhibit Hall D	View Abstract
W	321	Jenny Hernandez-Davies	UC Irvine	427	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Intranasal immunization as a route to needle-free, self administration of vaccines.	Exhibit Hall D	View Abstract
Th	322	Kimberly Celona	Northern Arizona University	431	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	BurkPx: A Multiplex Serodiagnostic Bead Assay To Monitor Burkholderia pseudomallei Exposures In Non-Human Primates	Exhibit Hall D	View Abstract
Th	323	Na Young Kim	R&D Center, ABION INC., Seoul 08394, Republic of Korea	454	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Development of mRNA vaccine platform against emerging infectious disease	Exhibit Hall D	View Abstract
Th	324	Charles Shoemaker	USAMRIID	463	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Transcriptomic analysis reveals host miRNAs correlated with immune gene dysregulation during fatal disease progression in the Ebola virus cynomolgus macaque disease model	Exhibit Hall D	View Abstract
W	325	David Saunders	Uniformed Services University School of Medicine	564	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in otherwise healthy research laboratory workers operating in containment laboratories	Exhibit Hall D	View Abstract
Th	326	Jonathan Pinney	Gryphon Scientific LLC	609	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Understanding rodent and non-human primate (NHP) immunity to inform human modeling of biological agents	Exhibit Hall D	View Abstract
W	327	Douglas Reed	University of Pittsburgh	616	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Humoral and cellular immune correlates of protection for live, attenuated tularemia vaccines in the outbred New Zealand White rabbit.	Exhibit Hall D	View Abstract
Th	328	Ashley Bryan	United States Army Medical Research Institute of Infectious Diseases (USAMRIID)	654	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Monkeypox Virus Persists in the Testes of Nonhuman Primate Survivors	Exhibit Hall D	View Abstract
Th	329	David Trudil	New Horizons Diagnostics Corp	656	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Rapid Point of Care (POC) Lateral Flow Immunoassay (LFI) assays for Salivary Mucosal IgA and IgG for the determination of Immune status against COVID-19	Exhibit Hall D	View Abstract
Th	330	Jan Sharon	University of California Irvine	694	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Development of single dose nanoparticle vaccines against select agent Coxiella burnetii	Exhibit Hall D	View Abstract
W	331	Crystal Burke	US Army Medical Research Institute of Infectious Diseases	722	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Effect of viral challenge dose on electroencephalogram (EEG) patterns from nonhuman primates aerosol exposed to Venezuelan equine encephalitis virus (VEEV)	Exhibit Hall D	View Abstract
Th	332	Xiankun Zeng	USAMRIID	724	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Ebola Virus Challenge Sites in the Skeletal Muscles of Nonhuman Primate as a Model to Study Disease Enhancement Mediated by Pre-existing Immunity	Exhibit Hall D	View Abstract
W	333	Cathryn Mayes	Sandia National Labs	180	Broad-Spectrum Therapeutics For Viral Diseases: A Medical Countermeasure Platform For Emerging Threats	Use of CRISPR-based antivirals as broad-spectrum therapeutics	Exhibit Hall D	View Abstract
Th	334	Delaney Davis	University of Chicago	763	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Multiple Coated PCL Microparticles for Single Administration Vaccine	Exhibit Hall D	View Abstract
W	335	Catherine Schein	UTMB-Galveston	84	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Broad spectrum protein-peptide antigens against encephalitic alphaviruses	Exhibit Hall D	View Abstract
Th	336	Oyewale Oyediran	University of ibadan , Brandeis University by August 2022	98	PALADINS: Protective Approaches Leveraging AD-aptive and IN-nate Systems	Monoclonal/Polyclonal Antibodies preparation to Investigate Lassa virus	Exhibit Hall D	View Abstract
W	337	Marco Pravetoni	University of Washington School of Medicine, Department of Psychiatry and Behavioral Sciences, Seattle, WA	578	Polyclonal Antibodies Against Multiple Chemical Threats	Vaccines and monoclonal antibodies to counteract synthetic opioids’ toxicity, poisoning, and lethality	Exhibit Hall D	View Abstract
W	339	Craig McElroy	The Ohio State University	682	Polyclonal Antibodies Against Multiple Chemical Threats	Efficacy of a Variety of Transition State Analogue Haptens in a Prophylactic Vaccine Against Organophosphorus Nerve Agent Exposure	Exhibit Hall D	View Abstract
W	341	William Morris	NuMat Technologies Inc.	104	Protection - Science and Technology Advances for Chemical and Biological Protection	Transitioning Metal-Organic Frameworks to Deployable Solutions for Warfighter Protection	Exhibit Hall D	View Abstract
Th	342	Bjoern Pedersen	Norwegian Defence Research Establishment (FFI)	116	Protection - Science and Technology Advances for Chemical and Biological Protection	Testing of particle filtering half masks during the coronavirus pandemic	Exhibit Hall D	View Abstract
W	343	Mitchell Weston	NuMat Technologies	132	Protection - Science and Technology Advances for Chemical and Biological Protection	Passive Filtration of Toxic Gases in Enclosed Spaces using Metal-Organic Framework Textile Composites	Exhibit Hall D	View Abstract
Th	344	Katherine Simpson	Arctos	140	Protection - Science and Technology Advances for Chemical and Biological Protection	Characterization of Zirconium Hydroxide and MOF-Doped Materials for CWA Neutralization	Exhibit Hall D	View Abstract
W	345	Joshua Uzarski	US Army DEVCOM Soldier Center	155	Protection - Science and Technology Advances for Chemical and Biological Protection	Low-dimensional nanomaterials for thin, elastomeric, durable barriers for chemical protection	Exhibit Hall D	View Abstract
Th	346	Pratibha Sinha	DEVCOM Soldier Center	175	Protection - Science and Technology Advances for Chemical and Biological Protection	Development of Improved Liquid Cooled Garment	Exhibit Hall D	View Abstract
Th	347	Hyunsook Jung	Agency for Defense Development	186	Protection - Science and Technology Advances for Chemical and Biological Protection	Short-chain fluorocarbon-based polymeric coating with excellent non wetting ability against chemical warfare agents	Exhibit Hall D	View Abstract
Th	348	Hyunsook Jung	Agency for Defense Development	188	Protection - Science and Technology Advances for Chemical and Biological Protection	Methodology of dynamic swatch cell testing in wind conditions to determine the penetration of aerosolized chemical warfare agents in a liquid phase for warfighter capabilities	Exhibit Hall D	View Abstract
W	349	Igor Novosselov	University of Washington	197	Protection - Science and Technology Advances for Chemical and Biological Protection	Continuous Flow MOF Synthesis in Supercritical CO2	Exhibit Hall D	View Abstract
Th	350	Jonathan Pham	University of Kentucky	200	Protection - Science and Technology Advances for Chemical and Biological Protection	Wetting and adhesion of soft and swollen polymeric interfaces	Exhibit Hall D	View Abstract
W	351	Shelle McDonald	Arctos	211	Protection - Science and Technology Advances for Chemical and Biological Protection	Investigating Surface Binding Effects: Antibacterial Efficacy of Bound 8-Hydroxyquinoline against Staphylococcus aureus and Escherichia coli	Exhibit Hall D	View Abstract
Th	352	Marilyn Lee	U.S. Army DEVCOM Chemical Biological Center	220	Protection - Science and Technology Advances for Chemical and Biological Protection	A cell-free polymer material platform: DNA-encoded smart materials for sensing and decontamination	Exhibit Hall D	View Abstract
W	353	Trenton Tovar	U.S. Army DEVCOM Chemical Biological Center	232	Protection - Science and Technology Advances for Chemical and Biological Protection	Controlling the heterogeneous catalysis of zirconium clusters within porous scaffolds	Exhibit Hall D	View Abstract
Th	354	Howard Walls	Research Triangle Institute	249	Protection - Science and Technology Advances for Chemical and Biological Protection	Aerosol Testing of CB Protective Garments for the Female Warfighter	Exhibit Hall D	View Abstract
Th	356	Jamie Drew	Defence Science Technology Laboratory	263	Protection - Science and Technology Advances for Chemical and Biological Protection	Enhanced Environmental Test and Evaluation of Adsorbents for Respiratory Protection	Exhibit Hall D	View Abstract
W	357	Michael Zielinski	US Army Combat Capabilities Development Command-Soldier Center	277	Protection - Science and Technology Advances for Chemical and Biological Protection	Systems Development and Integration for Tactical All-Hazards Ensemble	Exhibit Hall D	Abstract unavailable.
Th	358	Kira Baugh	NSWC Indian Head	283	Protection - Science and Technology Advances for Chemical and Biological Protection	Measuring breakthrough performance of Chemical, Biological and Radiological (CBR) gas filter media in extreme high humidity	Exhibit Hall D	View Abstract
W	359	Aleksandr Noy	Lawrence Livermore National Laboratory	302	Protection - Science and Technology Advances for Chemical and Biological Protection	Controlled mass transport in highly-confined 1D and 2D nanofluidic material platforms	Exhibit Hall D	View Abstract
W	361	Mary Okorie	Seton Hall University	310	Protection - Science and Technology Advances for Chemical and Biological Protection	Fluorine Interfaced Reactive Materials for Proactive Reduction of Threats	Exhibit Hall D	View Abstract
W	363	Martijn de Koning	TNO Defence, Safety & Security	317	Protection - Science and Technology Advances for Chemical and Biological Protection	Metal−organic framework/textile composites for the rapid and sensitive assessment of exposure to a toxic organophosphonate	Exhibit Hall D	View Abstract
Th	364	Patricia Bigrig	US ARMY DEVCOM SC	321	Protection - Science and Technology Advances for Chemical and Biological Protection	Functional Clothing Design for the Tactical All Hazards Ensemble	Exhibit Hall D	View Abstract
W	365	Cody Kendig	U.S. Army DEVCOM Chemical Biological Center	326	Protection - Science and Technology Advances for Chemical and Biological Protection	Proof of Concept Respirator Lens Fog Test Chamber	Exhibit Hall D	View Abstract
Th	366	Seung Jung Yu	Agency for Defense Development	332	Protection - Science and Technology Advances for Chemical and Biological Protection	Development of a vapor-based polymeric adhesive layer for the lamination of separation membranes and its application to aerosol protection	Exhibit Hall D	View Abstract
Th	368	Stephanie Wilson	NAVSEA	371	Protection - Science and Technology Advances for Chemical and Biological Protection	Is the Navy five-year periodicity to size and fit chemical biological radiological defense protective masks sufficient?	Exhibit Hall D	View Abstract
W	369	Joe Rossin	Guild Associates, Inc.	374	Protection - Science and Technology Advances for Chemical and Biological Protection	Advanced Barrier Materials for Chemical Defense	Exhibit Hall D	View Abstract
Th	370	Kristian Van de Voorde	ORISE Fellow support to U.S. Army DEVCOM Chemical Biological Center	380	Protection - Science and Technology Advances for Chemical and Biological Protection	The Volume-Saving Elastomer Networks for Operational Materiel (VENOM) Product Suite: Utilizing advanced manufacturing techniques to produce lower-burden respiratory protective equipment	Exhibit Hall D	View Abstract
W	371	James Lee	NSWCIH	385	Protection - Science and Technology Advances for Chemical and Biological Protection	Filter performance and the counter intuitive nature of CT requirements	Exhibit Hall D	View Abstract
Th	372	Tara Coia	The Nonwovens Insitute- NC State University	386	Protection - Science and Technology Advances for Chemical and Biological Protection	Development of Adsorbent System Against Chemical Threats	Exhibit Hall D	View Abstract
W	373	Trenton Tovar	U.S. Army DEVCOM Chemical Biological Center	391	Protection - Science and Technology Advances for Chemical and Biological Protection	Extended life filter for chemical biological radiological and nuclear (CBRN) protection	Exhibit Hall D	View Abstract
Th	374	Jennifer Poole	Teledyne FLIR Detection, Inc.	403	Protection - Science and Technology Advances for Chemical and Biological Protection	Lightweight modifications of existing PPE for improved bioprotection	Exhibit Hall D	View Abstract
W	375	John Mahle	U.S. Army DEVCOM Chemical Biological Center	416	Protection - Science and Technology Advances for Chemical and Biological Protection	Role of Zirconium metal-organic framework defects on chemical warfare agent performance studied through novel synthesis and mass transfer methods	Exhibit Hall D	View Abstract
Th	376	Jiwoong Heo	Agency for Defense Development	432	Protection - Science and Technology Advances for Chemical and Biological Protection	Graphene oxide/polymer hybrid membrane based on hydrogen bonding and size sieving effect for chemical warfare agent blocking.	Exhibit Hall D	View Abstract
W	377	Jaekyung Bae	Agency for defense devolpment, south korea	438	Protection - Science and Technology Advances for Chemical and Biological Protection	Real time analysis and computational models of CWAs penetration through swatches of various protective layer	Exhibit Hall D	View Abstract
Th	378	Natalie Pomerantz	DEVCOM Soldier Center	444	Protection - Science and Technology Advances for Chemical and Biological Protection	Agent Permeation and Decontamination Through Reactive Textile Composites	Exhibit Hall D	View Abstract
W	379	Kyeong Min Cho	Agency for Defense Development	447	Protection - Science and Technology Advances for Chemical and Biological Protection	Breathable ZIF/GO membranes for protection of chemical warfare agents	Exhibit Hall D	View Abstract
Th	380	Kyeong Min Cho	Agency for Defense Development	451	Protection - Science and Technology Advances for Chemical and Biological Protection	Highly Durable Membranes with Carbon Nanomaterials for Protection of Chemical Warfare Agent	Exhibit Hall D	View Abstract
W	381	Erin Anderson	US Army DEVCOM Soldier Center	462	Protection - Science and Technology Advances for Chemical and Biological Protection	Protecting the Suit that Protects the Soldier	Exhibit Hall D	View Abstract
Th	382	Joseph Palomba	U.S. Army DEVCOM Soldier Center	466	Protection - Science and Technology Advances for Chemical and Biological Protection	Atomic Force Microscopy as a Tool for Understanding the Interface of Metal-Organic Frameworks and Polymers	Exhibit Hall D	View Abstract
W	383	Nada Abdelaziz	Missouri University of Science and Technology	491	Protection - Science and Technology Advances for Chemical and Biological Protection	Composite MOF/Zr(OH)4-Polymer Catalytic Filters for in-situ Removal and Destruction of Chemical Warfare agents	Exhibit Hall D	View Abstract
W	385	D. Andrew Knight	Florida Institute of Technology	511	Protection - Science and Technology Advances for Chemical and Biological Protection	Cobalt(III)- and rhodium(III)-porphyrin complexes for the effective neutralization of opioids	Exhibit Hall D	View Abstract
W	387	Sanchao Liu	Army Research Lab	542	Protection - Science and Technology Advances for Chemical and Biological Protection	Silk protein nanofiber filter with antiviral activity against viral aerosols	Exhibit Hall D	View Abstract
Th	388	Fateme Rezaei	Missouri University of Science & Technology	552	Protection - Science and Technology Advances for Chemical and Biological Protection	Composite MOF/Zr(OH)4-Polymer Catalytic Filters for in-situ Removal and Destruction of Chemical Warfare Agents and Other Toxic Chemicals	Exhibit Hall D	Abstract unavailable.
W	389	Corie Ralston	Lawrence Berkeley National Lab	554	Protection - Science and Technology Advances for Chemical and Biological Protection	Development of peptoid-based nanoparticle conjugates for chemical and biological warfare agent detection and mitigation	Exhibit Hall D	View Abstract
W	390	Walter Zukas	U.S. Army DEVCOM SC, Natick, MA	555	Protection - Science and Technology Advances for Chemical and Biological Protection	Elastomer Laminates for Chemical Protection	Exhibit Hall D	View Abstract
W	391	Walter Zukas	U.S. Army DEVCOM Soldier Center, Natick, MA	556	Protection - Science and Technology Advances for Chemical and Biological Protection	Breathable Elastomers with Chemical and Biological Protection	Exhibit Hall D	View Abstract
Th	392	Sergio Garibay	Leidos Inc. support to U.S. Army DEVCOM Chemical Biological Center	567	Protection - Science and Technology Advances for Chemical and Biological Protection	Enhancing catalytic activity and mitigating poisoning of active sites within metal-organic frameworks in organophosphate hydrolysis through post-synthesis modification	Exhibit Hall D	View Abstract
W	393	James Varnum	US Army Combat Capabilities Development Command (DEVCOM) Solider Center	584	Protection - Science and Technology Advances for Chemical and Biological Protection	Effects of laundering on adsorption-based fabric systems	Exhibit Hall D	View Abstract
Th	394	Paul DeSario	U.S. Naval Research Laboratory	590	Protection - Science and Technology Advances for Chemical and Biological Protection	Oxide aerogels with enhanced sorptive and degradative activity for acute chemical threats	Exhibit Hall D	View Abstract
W	395	Seon Joo Park	Korea Research Institute of Bioscience and Biotechnology (KRIBB)	602	Protection - Science and Technology Advances for Chemical and Biological Protection	Ultrasensitive chemical nerve agent sensors	Exhibit Hall D	View Abstract
Th	396	Kamalesh Sirkar	New Jersy institute of technology	630	Protection - Science and Technology Advances for Chemical and Biological Protection	Graphene oxide and metal organic framework based breathable barrier membrane for toxic vapors	Exhibit Hall D	Abstract unavailable.
W	397	Min-Kun Kim	Agency for Defense Development	661	Protection - Science and Technology Advances for Chemical and Biological Protection	Multi-purpose high air/water permeable membrane for CBRN protection	Exhibit Hall D	View Abstract
Th	398	Ari Giaya	LaunchBay LLC	663	Protection - Science and Technology Advances for Chemical and Biological Protection	Fluorine-Free Biaxially Stretchable Barrier Fabric for NFPA Class I Ensemble	Exhibit Hall D	Abstract unavailable.
W	399	Mikaela Boyanich	Virginia Tech	699	Protection - Science and Technology Advances for Chemical and Biological Protection	Fundamental Studies of Metal-Organic Framework-Supported Single Metal Atoms for the Capture and Decomposition of Toxic Compounds: Mechanistic Insight into Carbon Monoxide Oxidation	Exhibit Hall D	View Abstract
Th	400	Danya Nahas	Virginia Tech	700	Protection - Science and Technology Advances for Chemical and Biological Protection	Mechanistic Studies of CO Oxidation Over Single Atom Catalysts Supported by Metal-Organic Frameworks	Exhibit Hall D	View Abstract
W	401	Chad Roy	Tulane University School of Medicine	717	Protection - Science and Technology Advances for Chemical and Biological Protection	A Miniaturized Electrostatic Precipitator Respirator Effectively Removes Ambient SARS-CoV-2 Bioaerosols	Exhibit Hall D	View Abstract
Th	402	Jamie Monico	Luna Labs USA	766	Protection - Science and Technology Advances for Chemical and Biological Protection	Next Generation Tactile CBRN Gloves via Polymer Mixed Matrix Composite	Exhibit Hall D	View Abstract
W	403	Arshia Sulaiman	Virginia Tech	99	Protection - Science and Technology Advances for Chemical and Biological Protection	Engineering Scaffolds for Chemical Warfare Agent Uptake and Destruction	Exhibit Hall D	View Abstract
Th	404	Michael Malfatti	Lawrence Livermore National Laboratory, Biosciences and Biotechnology Division	111	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	The effect of time and sequence on organophosphate and opioid antidote administration after exposure to organophosphates	Exhibit Hall D	View Abstract
Th	406	Janice Chambers	Mississippi State University	178	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Novel substituted phenoxyalkyl pyridinium oximes alone and in combination with 2-PAM provide improved survival and attenuation of OP-induced toxic signs in rats and guinea pigs	Exhibit Hall D	View Abstract
W	407	Nathan Unsworth	Defence Science and Technology Group	204	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Assessment of antibiotics using the hollow fibre infection model to identify improved melioidosis therapeutics	Exhibit Hall D	View Abstract
Th	408	Satya Achanta	Duke University	418	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Biomarkers, Drug Targets, and Repurposed Medical Countermeasures against Phosgene Inhalation Injuries	Exhibit Hall D	View Abstract
Th	410	Patrick McNutt	Wake Forest Institute for Regenerative Medicine	459	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Development of Human Organ Tissue Equivalents for Predictive Pathology and Medical Countermeasure Selection	Exhibit Hall D	View Abstract
W	411	Ian Gut	NBACC	482	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Characterizing medical countermeasure efficacy against aerosol administration of Bacillus cereus biovar anthracis Cameroon and Cote d'Ivoire in the New Zealand white rabbit model.	Exhibit Hall D	View Abstract
Th	412	Thomas Burke	Center for Environmental Health Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS 39762	494	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Novel Substituted Phenoxyalkyl Pyridinium Oximes Display Improved Pharmacokinetic Parameters as Compared to 2-PAM	Exhibit Hall D	View Abstract
Th	413	Todd Myers	USAMRICD	498	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	The Göttingen Minipig as a Large Animal Model for Medical Countermeasure Development: Overview of Benefits and Recent Strides Forward	Exhibit Hall D	View Abstract
Th	414	Todd Myers	USAMRICD	502	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	A Non-Human Primate Model of Carfentanil Overdose: Rescue Treatments that Completely Prevent Renarcotization	Exhibit Hall D	View Abstract
W	415	Gita Shankar	SRI International, Pharmaceutical Sciences Group, Biosciences Division, Menlo Park, CA	572	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	High-dose Naloxone formulation for intramuscular or intravenous administration	Exhibit Hall D	View Abstract
Th	416	Antonina Simakova	BioHybrid Solutions LLC	574	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Agent Catalytic Enzyme Scavengers (ACES) for Nerve Agent Prophylaxis	Exhibit Hall D	Abstract unavailable.
W	417	David Rozak	USAMRIID	582	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Developing and characterizing panels of single and multi-drug resistant bacterial surrogates for use in evaluating novel and repurposed therapeutic compounds	Exhibit Hall D	View Abstract
Th	418	Aishwarya Sriraman	Oak Ridge Institute for Science and Education / United States Army Medical Research Institute of Chemical Defense	586	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Effects of Both Inherent Chemical Structure and Environmental Conditions on the Enzyme-Small Molecule Relationship of a Non-Oxime Reactivator of Organophosphorus-Inhibited Human Acetylcholinesterase	Exhibit Hall D	View Abstract
W	419	Vanessa Dunn	Oak Ridge Institute of Science and Education Program; United States Army Medical Research Institute of Chemical Defense	599	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Development of a Multi-Agent Screening Assay for Novel Reactivators of Organophosphorus-Inhibited Human Acetylcholinesterase	Exhibit Hall D	View Abstract
Th	420	Kazunori Koide	University of Pittsburgh	626	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	New synthetic analogs of 2-pralidoxime with a broader spectrum against organophosphorus nerve agents	Exhibit Hall D	View Abstract
W	421	Emily Luteran	Los Alamos National Laboratory	672	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Characterization of diketopiperazine shuttles for improved transport of therapeutics across the blood-brain barrier	Exhibit Hall D	View Abstract
W	422	Christopher Hadad	Ohio State University	679	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Resurrecting the dead: Recovery of organophosphorus poisoned acetylcholinesterase using quinone methide precursors	Exhibit Hall D	View Abstract
W	423	Christopher Hadad	Ohio State University	683	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Bridging the Gap: Providing Selectivity and Specificity for Potential Therapeutics Against Organophosphorus Intoxication by Connecting Quinone Methide Precursors to Peripheral Binding Site Linkers	Exhibit Hall D	View Abstract
W	425	Kevin Miller	The Ohio State University - Hadad Lab	695	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Towards a Pseudo-Catalytic Bioscavenger: in vitro Reactivation of Organophosphorus-Inhibited and Resurrection of Organophosphorus-Aged Butyrylcholinesterase by Quinone Methide Precursors	Exhibit Hall D	View Abstract
Th	426	Shawn Blumberg	Southwest Research Institute	686	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Synthesis Development and Optimization of Scopolamine	Exhibit Hall D	View Abstract
Th	427	Shawn Blumberg	Southwest Research Institute	721	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Synthesis Development and Optimization of HLö7 DMS	Exhibit Hall D	View Abstract
Th	428	Ashley Peralta	LANL	726	Repurposing to Speed Chemical and Biological Medical Countermeasure Discovery and Development	Design and Synthesis of Diketopiperazine (DKP) as Shuttles for Therapeutics Across the Blood-Brain Barrier	Exhibit Hall D	View Abstract
W	429	Keith Brown	Jumpcode Genomics, Inc.	138	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	A UNIVERSAL ‘DAY ZERO’ INFECTIOUS DISEASE TESTING STRATEGY EXPLOITING CRISPR-BASED SAMPLE DEPLETION AND METAGENOMIC SEQUENCING	Exhibit Hall D	View Abstract
Th	430	Wenting Shao	University of Pittsburgh	156	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	A Carbon Nanotube-Based Field-Effect Transistor Biosensor for the Detection of Fentanyl Exposure	Exhibit Hall D	View Abstract
W	431	Armand Paauw	TNO	195	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Proteomics an agnostic approach to detect emerging viruses	Exhibit Hall D	View Abstract
Th	432	Manohar John	Pathovacs Incorporated	201	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	A simple and rapid lateral flow assay for accurate diagnosis of acute human Brucella melitensis infection	Exhibit Hall D	View Abstract
W	433	Jennifer Lee	DTRA support to U.S. Army DEVCOM Chemical Biological Center	258	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Alternative reporters for paper-based cell-free biosensing	Exhibit Hall D	View Abstract
Th	434	Keersten Ricks	USAMRIID	279	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Development of a diagnostic toolbox for detection and surveillance of Crimean-Congo Hemorrhagic Fever Virus	Exhibit Hall D	View Abstract
W	435	Kyle Clark	Darwin Biosciences	281	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Overcoming challenges of using saliva as a biospecimen in rapid diagnostic tests	Exhibit Hall D	View Abstract
Th	436	Michael Wiederoder	US Army DEVCOM Soldier Center	290	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Rapid Colorimetric Sensors to Detect Toxic Chemicals in Environmental Samples	Exhibit Hall D	View Abstract
W	437	Dan Phillips	U.S. Army DEVCOM Chemical Biological Center	328	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Rapid testing and validation of gene-based sensors for the detection of SARS-CoV-2	Exhibit Hall D	View Abstract
Th	438	Aleksandr Miklos	US Army DEVCOM Chemical Biological Center	343	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Development of a paper-based cell-free expression device for biological sensing	Exhibit Hall D	View Abstract
W	439	Daniel Phillips	U.S. Army DEVCOM Chemical Biological Center	353	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Optimizing cell-free reaction composition to accelerate toehold switch sensor response time	Exhibit Hall D	View Abstract
Th	440	Rebecca Blackwood	Darwin Biosciences	372	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	An analysis of isothermal amplification chemistries for use in point-of-need diagnostic devices	Exhibit Hall D	View Abstract
W	441	Scott Bobbitt	Sandia National Laboratories	373	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Rapid, agile, and portable diagnostics based on breath biomarkers using highly-selective sorbents	Exhibit Hall D	View Abstract
Th	442	Michael Norris	University of Florida Emerging Pathogens Institute	411	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Immediate results: an FPA for detection of glanders and melioidosis exposure.	Exhibit Hall D	View Abstract
Th	443	Julian Chen	LANL	419	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Solution NMR structure of DFPase: Prospects for molecular level detection and large-scale decontamination of organophosphorus compounds	Exhibit Hall D	View Abstract
W	444	Weihua Guan	The Pennsylvania State University	420	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	iNAAT: A universal open-source mobile device for field deployable real-time isothermal nucleic acid amplification testing of Covid-19	Exhibit Hall D	View Abstract
W	445	Weihua Guan	Penn State University	421	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Fingerpick Blood-Based HIV Self-Nucleic Acid Testing on USB At The Point of Need	Exhibit Hall D	View Abstract
Th	446	Dawn Birdsell	Pathogen and Microbiome Institute	425	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Capillary blood is an effective clinical matrix for rapid diagnosis of acute plague in field forward settings	Exhibit Hall D	View Abstract
W	447	Weihua Guan	Pennsylvania State University	428	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Amplification Free Digital CRISPR-Cas13a for Absolute Quantification of HIV-1 RNA	Exhibit Hall D	View Abstract
Th	448	Julia Patrone	JHU/APL	439	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Detection of Volatile Organic Compounds in Biological Samples Associated with Infection	Exhibit Hall D	View Abstract
W	449	Anthony Politza	Penn State University	441	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Programmable Magnetic Robot (ProMagBot) for Automated Nucleic Acid Extraction at the Point of Need	Exhibit Hall D	View Abstract
W	451	Darci Smith	Naval Medical Research Center, Biological Defense Research Directorate	468	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Detection of Biomarkers of Neurological Injury for Emerging Viral Threats	Exhibit Hall D	View Abstract
Th	452	Svetlana Harbaugh	711th Human Performance Wing, Wright-Patterson Air Force Base, OH, UES, Inc., Dayton, OH	487	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Development of Cell-Free Biosensors for Deployable Diagnostics	Exhibit Hall D	View Abstract
W	453	David Garcia	NRC support to U.S. Army DEVCOM Chemical Biological Center	506	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Simplified cells as new tools for synthetic biology and biological sensing	Exhibit Hall D	View Abstract
Th	454	John Cooper	Pacific Northwest National Laboratory	508	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Machine Learning Techniques for Threat Classification on Ion Mobility Spectroscopy: A Survey of Methods	Exhibit Hall D	View Abstract
W	455	Kurt Gust	US Army Engineer Research and Development Center	529	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	RNA-Toehold Switch Technology Enables Customizable Biological Threat Detection	Exhibit Hall D	View Abstract
Th	456	Chris Myers	Parsons	544	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	DetectWise™, an automated, integrated biosurveillance platform for managing health security	Exhibit Hall D	View Abstract
W	457	Aarthi Narayanan	GMU	558	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Pathogen-derived circulating nucleic acids as biomarker candidates for assessment of countermeasures against aerosol-transmitted viral pathogens	Exhibit Hall D	View Abstract
Th	458	Michael Wiederoder	US Army DEVCOM Soldier Center	559	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Rapid Electrochemical Immunoassays for Low-Cost, Multiplex Detection of Food Pathogens using Capillary Driven Microfluidic Devices	Exhibit Hall D	View Abstract
W	459	William Terziyan	BaySpec, Inc.	565	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Threat agnostic ultrafast femtosecond laser photonic molecular sensing platform: Label-free diagnostics based on miniaturized coherent anti-stokes raman spectroscopy (FT-CARS)	Exhibit Hall D	View Abstract
Th	460	Alex Downs	Sandia National Laboratories	575	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Electrochemical aptamer-based sensors: a field-applicable approach for real-time monitoring of small molecule targets and beyond.	Exhibit Hall D	View Abstract
W	461	Oh Seok Kwon	Korea Research Institute of Bioscience and Biotechnology (KRIBB)	603	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Ultrasensitive Stress Biomarker Detection Using Polypyrrole Nanotube Coupled to a Field-Eﬀect Transistor	Exhibit Hall D	View Abstract
Th	462	Gyeong Ji Kim	Korea Research Institute of Bioscience and Biotechnology	605	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Simple and Fast Real-Time Monitoring Wearable Cortisol Aptasensor	Exhibit Hall D	View Abstract
W	463	Julie L Lucas	MRIGlobal	608	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Immobilized CRISPR chemistry for massively multiplexed target detection	Exhibit Hall D	View Abstract
Th	464	Mangilal Agarwal	Integrated Nanosystems Development Institute, Department of Mechanical Engineering, Indiana University-Purdue University Indianapolis	610	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Development of a Rapid Method to Quantify Healthy Baselines of Volatile Organic Compound (VOC) Biomarkers in Breath by Solid Phase Microextraction and Gas Chromatography-Mass Spectrometry	Exhibit Hall D	View Abstract
W	465	Sean Webb	711th Human Performance Wing, AFRL ; UES, Inc	612	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	A platform for rapid design and discovery of BREs for emerging threats	Exhibit Hall D	View Abstract
Th	466	Mangilal Agarwal	Integrated Nanosystems Development Institute, Department of Mechanical Engineering, Indiana University-Purdue University Indianapolis	614	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Optimizing Portable Metal Oxide Nanosensors to Analyze Exhaled Volatile Organic Compounds (VOCs)	Exhibit Hall D	View Abstract
W	467	Canon Hansen	USAMRIID	618	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Supporting the warfighter by developing safe and effective controls for field deployable molecular assays and immunoassays	Exhibit Hall D	View Abstract
Th	468	Tek Hyung Lee	Lawrence Livermore National Laboratory	621	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Developing yeast whole-cell biosensor for potential pathogen detection	Exhibit Hall D	View Abstract
W	469	Syamal Raychaudhuri	InBios International, Inc.	627	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	The Smart Detect POC PCR Platform is a Multi-use, Portable Device for the Detection of Infectious Agents	Exhibit Hall D	View Abstract
Th	470	Matthias Frank	Lawrence Livermore National Laboratory	631	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Characterization of VOCs Emitted from Pathogenic Bacteria Using SPME-GC-MS: Towards Non-Invasive Diagnostics for Biological Agent Exposure	Exhibit Hall D	View Abstract
W	471	Kyung Ho Kim	Korea Research Institute of Bioscience and Biotechnology (KRIBB)	644	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Portable field-effect transistor for serotonin neurotransmitter monitoring on-site	Exhibit Hall D	View Abstract
Th	472	Kimberly Butler	Sandia National Laboratories	652	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Development of a tunable Metal-Organic Frameworks (MOFs)-DNA sensor platform for rapid viral detection	Exhibit Hall D	View Abstract
W	473	Jeff Koehler	US Army Medical Research Institute of Infectious Diseases	673	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Rapid assay fielding for diagnostics and detection	Exhibit Hall D	View Abstract
Th	474	Deborah Hunka	Leidos	680	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	“Smart” Colorimetric Sorbent Sensors for Selected CWAs	Exhibit Hall D	Abstract unavailable.
W	475	Philip Miller	Sandia National Labs	687	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Portable biogenic Volatile Organic Compound Analyzer	Exhibit Hall D	View Abstract
Th	476	Noah Christian	Leidos	709	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	A Low-Cost, Low-Power, Miniature Sector Arrayed Mass Spectrometer for Chemical and Biological Detection Applications	Exhibit Hall D	View Abstract
W	477	Megan Roegner	GeneCapture	734	Revolutionary Diagnostics – Nontraditional Approaches for Developing Breakthrough Capabilities Against Emerging Threats	Unknown respiratory pathogen detector using pan-species signatures	Exhibit Hall D	View Abstract
Th	478	Prabha Dwivedi	Naval Surface Warfare Center Indian Head Division (NSWC IHD)	110	The Impact Of Giving Warfighters A Voice In Early Technology Development	In-Ear Wearable Device at Chemical and Biological Operational Analysis (CBOA) Events	Exhibit Hall D	View Abstract
W	479	David Godso	Domenix	117	The Impact Of Giving Warfighters A Voice In Early Technology Development	Utilizing Development Security Operations (DevSecOps) Platforms to Support Science and Technology (S&T) Collaboration with a Focus on "Shift-Left" Portfolio and Capability Set(s) Insight	Exhibit Hall D	View Abstract
Th	480	John Magerko	ARA, Inc. - DTRA Reachback Support	315	The Impact Of Giving Warfighters A Voice In Early Technology Development	Reviewing How Early and Frequent User Inputs Impacted a Particular HPAC Model Design	Exhibit Hall D	View Abstract
W	481	Charles Lansing	NSWCIH	324	The Impact Of Giving Warfighters A Voice In Early Technology Development	OPNAV N96 Trusted agent support for the DTRA Warfighter and Integration Division for all Navy CBR	Exhibit Hall D	View Abstract
Th	482	David Wagner	Northern Arizona University	105	Threat Agent Defeat Modeling and Testing	Isolation-free genomic characterization of biological threat agents from complex samples	Exhibit Hall D	View Abstract
W	483	Joseph Baum	Applied Simulations, Inc	122	Threat Agent Defeat Modeling and Testing	NUMERICAL MODELING OF LIQUID DISPERSION BY AN EXPLOSIVE CHARGE	Exhibit Hall D	View Abstract
Th	484	Fumiya Togashi	Applied Simulations Inc.	126	Threat Agent Defeat Modeling and Testing	Numerical Investigation of Liquid Simulant Response to Blast Wave	Exhibit Hall D	View Abstract
W	485	Terrence Meyer	Purdue University	127	Threat Agent Defeat Modeling and Testing	Measurements of DIMP and ethanol evaporation rates for validation of high-temperature phenomenological models	Exhibit Hall D	View Abstract
Th	486	Sun McMasters	DHS S&T CSAC	129	Threat Agent Defeat Modeling and Testing	Jack Rabbit III: Filling Critical Atmospheric Dispersion Modeling Gaps for Emergency Planning and Response	Exhibit Hall D	View Abstract
W	487	Jeldrik Moritz	Bundeswehr Research Institute for Protective Technologies and NBC-Protection	150	Threat Agent Defeat Modeling and Testing	Rejection of Lewisite and Other Arsenicals by Reverse Osmosis Membranes - Impact of Temperature, pH-value and Recovery	Exhibit Hall D	View Abstract
Th	488	Andrew Proulx	Johns Hopkins University	163	Threat Agent Defeat Modeling and Testing	Materials Science in Extreme Environments University Research Alliance	Exhibit Hall D	View Abstract
Th	490	Cale Bergmann	Defence Research and Development Canada (DRDC)	304	Threat Agent Defeat Modeling and Testing	Aerosol Deposition Model for Simulating the Distribution of Deposited Aerosolized Particles on a Mannequin	Exhibit Hall D	View Abstract
W	491	Tiffany Sutton	U.S. Army DEVCOM Chemical Biological Center	330	Threat Agent Defeat Modeling and Testing	Synthetic Dynamic Background Recipe Development for Biological Testing	Exhibit Hall D	View Abstract
W	493	Colin Ponce and Kourosh Arasteh	LLNL	345	Threat Agent Defeat Modeling and Testing	Harnessing the Power of Machine Learning to Identify Novel Chemical Threats in Complex Forensic Environments	Exhibit Hall D	View Abstract
Th	494	Jana Kesavan	U.S. Army DEVCOM Chemical Biological Center	351	Threat Agent Defeat Modeling and Testing	Decay of clusters and single spores of Bacillus anthracis Sterne in air, on surfaces and in simulated aerosol state and exposed to environmental factors	Exhibit Hall D	View Abstract
W	495	James Lee	NSWCIH	384	Threat Agent Defeat Modeling and Testing	CBR defense technologies and non-covalent chemistry interactions	Exhibit Hall D	View Abstract
Th	496	Janine Hutchison	Pacific Northwest National Laboratory	426	Threat Agent Defeat Modeling and Testing	Stabilization of Biological Proteins Using Tunable Liquid Materials	Exhibit Hall D	View Abstract
W	497	Aaron Twombly	MRIGlobal	448	Threat Agent Defeat Modeling and Testing	Improved chemical and biological defense testing using the Test Grid operated with the Open Architecture Data Management System	Exhibit Hall D	View Abstract
Th	498	Tom Spicer	University of Arkansas Department of Chemical Engineering	538	Threat Agent Defeat Modeling and Testing	Ensemble behavior of passive, time-limited, area source releases in a wind tunnel study	Exhibit Hall D	View Abstract
W	499	Doo Nam Kim	Pacific Northwest National Laboratory	568	Threat Agent Defeat Modeling and Testing	Facile incorporation of non-canonical amino acids into structural modeling	Exhibit Hall D	View Abstract
Th	500	Richard Overstreet	Pacific Northwest National Laboratory	569	Threat Agent Defeat Modeling and Testing	Non-canonical amino acid parameterization engine for CHARMM potentials	Exhibit Hall D	View Abstract
W	501	Andrew Banko	United States Military Academy	620	Threat Agent Defeat Modeling and Testing	Measurements of three-dimensional flow and contaminant dispersion within and around a stadium using magnetic resonance imaging	Exhibit Hall D	View Abstract
Th	502	David Doughty	US Army DEVCOM Army Research Laboratory	625	Threat Agent Defeat Modeling and Testing	Aerosol Particle Size is Important in Designing and Testing UV Systems for Inactivation of Bacterial Spores and Viruses as Seen in Modeling of UV Shielding	Exhibit Hall D	View Abstract
W	503	Isaac Avina	Sandia National Laboratories	633	Threat Agent Defeat Modeling and Testing	Impedance monitoring of polymer dielectrics in harsh environments	Exhibit Hall D	Abstract unavailable.
Th	504	Nicole Ford	Kansas City University	112	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Developing Novel Detection Methods for Use with Biosilica-Immobilized Nanoscale Biosensors	Exhibit Hall D	View Abstract
W	505	Justin Bickford	CCDC - Army Research Laboratory	142	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Chip-scale photonic integrated circuit sensor to monitor biomarkers and diagnose toxin exposures	Exhibit Hall D	View Abstract
Th	506	Fanny Chu	Pacific Northwest National Laboratory	219	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Direct detection of peptides following enzymatic cleavage using a field-portable nanopore sequencing device	Exhibit Hall D	View Abstract
W	507	Brian Kannard	PercuSense	406	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Continuous Biosensor Platform to Detect Indicators of Chemical Exposure	Exhibit Hall D	View Abstract
Th	508	Kristian Torma	BaySpec, Inc.	430	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Direct real-time trace vapors and aerosols chemicals characterization with a man-portable mass spectrometer	Exhibit Hall D	View Abstract
W	509	Guandong Zhang	Zymeron Corporation, 400 Park Offices Dr #211, Research Triangle Park, NC 27709	484	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Highly Sensitive and Selective Detection of Fentanyl and Other Opioids by Bioengineered Broad-Spectrum Receptors	Exhibit Hall D	View Abstract
Th	510	Matthew Turner	Pacific Northwest National Laboratory	635	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Portable and convenient identification of enzymatic activity by direct detection of cleaved peptides using a nanopore sequencing device	Exhibit Hall D	View Abstract
W	511	Jaime Rodriguez	Pacific Northwest National Laboratory	643	Toxin Diagnostics – Development Of Novel, Fieldable Technologies To Diagnose Toxin Exposure	Modeling Osmolyte Effects on Protein Toxin Structural Stability	Exhibit Hall D	View Abstract

DTRA JSTO DVIDS

Website powered by Chenega CITES

DTRA JSTO DVIDS

Website powered by Chenega CITES

DTRA JSTO DVIDS

Website powered by Chenega CITES